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Three Essays On Diabetes And Mortality In The United States
Abstract
Diabetes is on the rise. The world faces an emerging deadly threat on people’s health and nations’ publichealth systems with a large economic burden. According to the World Health Organization (WHO), the
number of people living with diabetes has risen from 108 million in 1980 to 422 million in 2014 (WHO,
2016). In the United States, more than 80 million people are living with diabetes or prediabetes and this
number is projected to double by 2050 (CDC, 2017).
Diabetes is a serious and life-threatening condition that occurs when the body cannot regulate blood
sugar. When diabetes is not appropriately controlled, it causes dire consequences for health and wellbeing of individuals. Furthermore, compelling empirical evidence has shown a strong association
between diabetes and premature death (Gu, Cowie and Harris, 1998). In 2016, the number of deaths in the
world due to diabetes was 1.6 million and this number is expected to increase (WHO, 2016). Thus,
reducing excess deaths from diabetes has been one of the main goals of global efforts, such as 2030
Agenda for Sustainable Development developed by the WHO (UN General Assembly, 2015). Accordingly,
public health policy makers and health providers have called for better diabetes prevention interventions
and disease management programs designed to reduce the risk of mortality due to diabetes.
This dissertation aims to contribute to these efforts by filling critical gaps in the previous literature on
diabetes and mortality. The gaps this dissertation focuses on are threefold. First, the fraction of total
deaths attributable to diabetes is seriously underestimated when an underlying cause of death on death
certificates is used to assess the contribution of diabetes to overall mortality, which is a commonly used
method to assess the contribution of diabetes to a national mortality profile. Second, despite a body of
literature on the association between diabetes and mortality, few prospective studies have examined this
association by using information on self-reported diagnosed diabetes and biomarkers of diabetes
measured at the start of the mortality follow-up (or baseline) simultaneously. Third, prior findings on
nativity disparities in diabetes in the United States have been inconsistent and most studies have relied
solely on self-reported diabetes, which may be biased due to immigrants’ limited access to healthcare.
Each of these three gaps is addressed in the following chapters. In Chapter 1, I examine the contribution
of diabetes to US life expectancy using a Population Attributable Fraction (PAF) approach. I found that life
expectancy at age 30 increases by 0.89 years when diabetes is eliminated based on the PAF, and this
estimate is much higher than a gain of 0.34 years based on underlying cause of death data. In Chapter 2, I
estimate the risk of death associated with diabetes using both self-reported diagnosed diabetes and a
level of HbA1c measured at baseline. Results show that self-reported diagnosed diabetes had a stronger
association with mortality than HbA1c at baseline, and individuals with self-reported diagnosed diabetes
were at a higher risk of death compared to those whose diabetes had not been previously diagnosed,
regardless of their diabetes status identified by baseline HbA1c level. In Chapter 3, I examine nativity
differentials in diabetes using self-reported diagnosed diabetes, HbA1c and undiagnosed diabetes. I find
that the foreign-born have a higher prevalence of diabetes than the US-born individuals, but that this
excess was explained by controls for sociodemographic characteristics and Body Mass Index (BMI). In
addition, I observe that among the foreign-born, those who had arrived in the United States in the last 15
years were less likely to have self-reported diabetes than those who had arrived earlier, suggesting that
the immigrant health advantage deteriorates with time in the United States. When diabetes was
diagnosed based on baseline HbA1c level, however, there was no such advantage for the short-term
immigrants over the long-term immigrants.
These findings suggest avenues for future research. First, it is important to consider the various ways in
which information on diabetes is collected in surveys and on death certificates in assessing its impact on

mortality. The results from Chapter 1 show that a focus on diabetes as an underlying cause of death
seriously underestimates its impact on life expectancy. Furthermore, Chapter 2 demonstrates that selfreported diagnosis of diabetes provides important information about the risk of death due to diabetes
beyond biomarkers measured at the start of the mortality follow-up. Thus, future studies need to consider
multiple ways in which diabetes is measured. Second, in Chapters 2 and 3, the issue of measurement is a
key focus and results from these chapters suggest that diverse measurements of diabetes should be
considered at the same time, not only because they reflect different aspects of diabetes, but also using
them together provides more comprehensive information on how diabetes is associated with mortality.
Third and most importantly, future research should seek to understand the mechanisms through which
diabetes contributes to mortality. Because all three chapters of this dissertation are based on crosssectional data, the current dissertation cannot directly examine the connections that link the onset of
diabetes to subsequent mortality. Patients who are diagnosed with diabetes are likely to experience
several changes in their life, such as modifications in health behaviors, using healthcare services and
taking medicine to control diabetes, and change the perception of their own health, which are likely to
affect the risk of death. Therefore, future research that accounts for these modifications will shed light on
the mechanisms associated with the onset of diabetes and subsequent mortality.
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INTRODUCTION
Diabetes is on the rise. The world faces an emerging deadly threat on people’s health
and nations’ public-health systems with a large economic burden. According to the World
Health Organization (WHO), the number of people living with diabetes has risen from 108
million in 1980 to 422 million in 2014 (WHO, 2016). In the United States, more than 80
million people are living with diabetes or prediabetes and this number is projected to double by
2050 (CDC, 2017).
Diabetes is a serious and life-threatening condition that occurs when the body cannot
regulate blood sugar. When diabetes is not appropriately controlled, it causes dire
consequences for health and well-being of individuals. Furthermore, compelling empirical
evidence has shown a strong association between diabetes and premature death (Gu, Cowie
and Harris, 1998). In 2016, the number of deaths in the world due to diabetes was 1.6 million
and this number is expected to increase (WHO, 2016). Thus, reducing excess deaths from
diabetes has been one of the main goals of global efforts, such as 2030 Agenda for Sustainable
Development developed by the WHO (UN General Assembly, 2015). Accordingly, public
health policy makers and health providers have called for better diabetes prevention
interventions and disease management programs designed to reduce the risk of mortality due to
diabetes.
This dissertation aims to contribute to these efforts by filling critical gaps in the
previous literature on diabetes and mortality. The gaps this dissertation focuses on are
threefold. First, the fraction of total deaths attributable to diabetes is seriously underestimated
when an underlying cause of death on death certificates is used to assess the contribution of
diabetes to overall mortality, which is a commonly used method to assess the contribution of
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diabetes to a national mortality profile. Second, despite a body of literature on the association
between diabetes and mortality, few prospective studies have examined this association by
using information on self-reported diagnosed diabetes and biomarkers of diabetes measured at
the start of the mortality follow-up (or baseline) simultaneously. Third, prior findings on
nativity disparities in diabetes in the United States have been inconsistent and most studies
have relied solely on self-reported diabetes, which may be biased due to immigrants’ limited
access to healthcare.
Each of these three gaps is addressed in the following chapters. In Chapter 1, I
examine the contribution of diabetes to US life expectancy using a Population Attributable
Fraction (PAF) approach. I found that life expectancy at age 30 increases by 0.89 years when
diabetes is eliminated based on the PAF, and this estimate is much higher than a gain of 0.34
years based on underlying cause of death data. In Chapter 2, I estimate the risk of death
associated with diabetes using both self-reported diagnosed diabetes and a level of HbA1c
measured at baseline. Results show that self-reported diagnosed diabetes had a stronger
association with mortality than HbA1c at baseline, and individuals with self-reported
diagnosed diabetes were at a higher risk of death compared to those whose diabetes had not
been previously diagnosed, regardless of their diabetes status identified by baseline HbA1c
level. In Chapter 3, I examine nativity differentials in diabetes using self-reported diagnosed
diabetes, HbA1c and undiagnosed diabetes. I find that the foreign-born have a higher
prevalence of diabetes than the US-born individuals, but that this excess was explained by
controls for sociodemographic characteristics and Body Mass Index (BMI). In addition, I
observe that among the foreign-born, those who had arrived in the United States in the last 15
years were less likely to have self-reported diabetes than those who had arrived earlier,
suggesting that the immigrant health advantage deteriorates with time in the United States.
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When diabetes was diagnosed based on baseline HbA1c level, however, there was no such
advantage for the short-term immigrants over the long-term immigrants.
These findings suggest avenues for future research. First, it is important to consider the
various ways in which information on diabetes is collected in surveys and on death certificates
in assessing its impact on mortality. The results from Chapter 1 show that a focus on diabetes
as an underlying cause of death seriously underestimates its impact on life expectancy.
Furthermore, Chapter 2 demonstrates that self-reported diagnosis of diabetes provides
important information about the risk of death due to diabetes beyond biomarkers measured at
the start of the mortality follow-up. Thus, future studies need to consider multiple ways in
which diabetes is measured. Second, in Chapters 2 and 3, the issue of measurement is a key
focus and results from these chapters suggest that diverse measurements of diabetes should be
considered at the same time, not only because they reflect different aspects of diabetes, but also
using them together provides more comprehensive information on how diabetes is associated
with mortality. Third and most importantly, future research should seek to understand the
mechanisms through which diabetes contributes to mortality. Because all three chapters of this
dissertation are based on cross-sectional data, the current dissertation cannot directly examine
the connections that link the onset of diabetes to subsequent mortality. Patients who are
diagnosed with diabetes are likely to experience several changes in their life, such as
modifications in health behaviors, using healthcare services and taking medicine to control
diabetes, and change the perception of their own health, which are likely to affect the risk of
death. Therefore, future research that accounts for these modifications will shed light on the
mechanisms associated with the onset of diabetes and subsequent mortality.
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ABSTRACT
THREE ESSAYS ON DIABETES AND MORTALITY IN THE UNITED STATES
Daesung Choi
Irma Elo

The dissertation aims to contribute to the ongoing debate on diabetes and
mortality by filling critical gaps unanswered in previous literature. Chapter 1 estimates
the contribution of diabetes on U.S. life expectancy using a Population Attributable
Fraction approach. Data are from National Health and Interview Survey 1997-2009
and Linked Mortality Files through 2011, and the official 2010 U.S. life tables. I found
that life expectation at age 30 increases by 0.89 years when diabetes is eliminated, and
this estimate is much higher than a gain of 0.34 years based on underlying cause of
death data. Chapter 2 investigates an association between diabetes and all-cause
mortality by considering self-reported diagnosed diabetes and HbA1c simultaneously.
Data are drawn from the National Health and Nutrition Examination Survey
(NHANES) 1988-1994, continuous NHANES 1999-2009 and Linked Mortality Files
through December 31, 2015. In primary analyses, the sample adults ages 30 to 84 are
categorized by self-reported diabetes and HbA1c criteria of ≥ 6.5%. Then relative risk
of death among these groups is estimated. When both measurements are jointly
considered in survival analysis, self-reported diabetes shows a much stronger
association with mortality than baseline HbA1c criteria. Results show that adults with
diagnosed diabetes are at an increased risk of death than those without diagnosed
diabetes, regardless of their baseline HbA1c status. Chapter 3 examines the existence
xii

of an immigrant health advantage in diabetes among the foreign-born compared to
their U.S.-born counterparts ages 30 to 80 using both self-reported diabetes and HbA1c
levels. Data used in this chapter are NHANES 1988-1994 and continuous NHANES
1999-2015. Logistic regression models are estimated to examine relative risk of selfreported diabetes, HbA1c ≥6.5% and undiagnosed diabetes among the foreign-born
relative to the U.S.-born. I found that A racial/ethnic composition and BMI play a role
in nativity disparities in diabetes. In addition, the foreign-born advantage in selfreported diabetes among those who have resided in the United States for less than 15
years is in part due to their higher prevalence of undiagnosed diabetes compared to that
of the US-born.
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CHAPTER 1

EFFECT OF DIABETES ON LIFE EXPECTANCY
IN THE UNITED STATES BY RACE/ETHNICITY AND GENDER1

Abstract
Background: The estimation of mortality attributable to diabetes has been typically
made based on information on death certificates which underestimates the true impact of
diabetes on the national mortality profile. Using Population Attributable Fraction (PAF),
this chapter estimates age-sex-race/ethnicity specific fraction of total deaths attributable
to diabetes in the United States. In addition, this chapter assesses the impact of diabetes
on life expectancy above age 30 by sex and race/ethnicity using PAFs.
Data and Methods: Data are from the public use 1997-2009 National Health Interview
Survey (NHIS) and Linked Mortality Files (LMF) and the official 2010 US life tables for
the entire US population and by sex and race/ethnicity. Mortality status of adults aged 30
and above were followed up from the survey through December 31, 2011. The outcome
is all-cause mortality and diabetes is identified by self-reported diagnosed diabetes. PAF
is a function of hazard of death associated with diabetes and prevalence of diabetes
among decedents. Hazard ratios are estimated by fitting Cox Proportional hazard models.
Estimated PAFs are applied to the US life table to obtain mortality rates and life
expectancy in the absence of diabetes. I also estimate the impact of diabetes on life
expectancy using the underlying cause of death data obtained from NHIS-LMF.
Results: Diabetes was responsible for a reduction of 0.83 and 0.89 years of life
expectancy for men and women at age 30, respectively. Non-Hispanic blacks and
Hispanics have higher prevalence of diabetes among deaths, but lower hazard of death
associated with diabetes compared with non-Hispanic whites. This results in comparable
PAF values and gains in life expectancy across race/ethnicity. Gains in life expectancy
based on an underlying cause of death are 0.33 for both men and women at age 30.
Conclusion: The number of deaths attributable to diabetes based on an underlying
cause of death is greatly underestimated. The more realistic estimation of mortality
rates attributable to diabetes should be employed to better identify the burden of
diabetes.
1
A version of this chapter has been previously published as appeared in Samuel H. Preston, Daesung
Choi, Irma T. Elo & Andrew Stokes (2018) Effect of diabetes on life expectancy in the United States by
race and ethnicity, Biodemography and Social Biology, 64:2, 139-151, DOI:
10.1080/19485565.2018.1542291
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1.1 Introduction
For the past decades, the prevalence of diabetes has increased dramatically in
the United States. In 1980, the age-adjusted prevalence of diagnosed diabetes was
3.7%, but increased to 8.3% in 2012 (Geiss et al., 2014). If current trends continue, the
number of people with diabetes is estimated to be 60.6 million in 2060, accounting for
17.9% of the total US population (Lin et al., 2018). As diabetes is one of the most
costly chronic diseases, the increasing number of adults with diabetes will impose a
substantial burden on healthcare resources in the future (American Diabetes
Association 2018).
Diabetes is associated with excess deaths and multiple complications, including
cardiovascular disease, stroke, cancer and hypertension (Gregg, Li, et al., 2014;
Saydah, Tao, Imperatore, & Gregg, 2009). The effect of diabetes on national mortality
profiles has been typically estimated based on national surveillance data that collect
information from death certificates (McEwen et al., 2006). Many researchers, however,
have pointed out that these estimates calculated based on an undying cause of death
may seriously underestimate the actual impact of the disease on the mortality profile of
the US population (Alva, Hoerger, Zhang, & Cheng, 2018; Roglic et al., 2005; Stokes
& Preston, 2017). The reason is that people with diabetes often die from diabetes
complications, especially cardiovascular events, rather than diabetes itself and these
complications tend to be mentioned as an underlying cause of death and diabetes may
not be listed anywhere on death certificates (Murray et al., 2008; Saydah et al., 2004).
One way to avoid this limitation is to use a Population Attributable Fraction (PAF)
2

approach, with which the fraction of total deaths attributable to diabetes in a population
can be estimated based on national survey data in which persons who have diabetes are
identifiable before death.
To date, many studies have employed the PAF approach to estimate the more
realistic contribution of diabetes to mortality (Alva et al., 2018; Roglic et al., 2005;
Stokes & Preston, 2017). One limitation of these studies is that the literature did not
estimate PAFs separately by age, sex and race/ethnicity. Given considerable
heterogeneity in terms of the prevalence of diabetes and mortality by these
demographic characteristics, an estimate for the entire US population does not capture
how diabetes affects mortality by such sociodemographic characteristics.
Therefore, this chapter aims to estimate age-specific PAFs for males and
females and racial/ethnic groups separately. Then the estimated PAFs will be applied
to the official US life tables to obtain gain in life expectancy when eliminating deaths
attributable to diabetes by sex and race/ethnicity. Furthermore, gains in life expectancy
and probability of dying in the absence of diabetes based on PAFs will be compared
with values based on an underlying cause of death.

1.2 Literature Review
1.2.1 Trends in Diabetes Prevalence and Mortality
The number of people with diabetes in the world has increased at an alarming
rate. An estimated number of adults living with diabetes was 108 million in 1980 and
3

this number has more than tripled by 2014 (Zhou et al., 2016). The United States is not
the exception in this global diabetes epidemic. The nationwide age-adjusted prevalence
of people with self-reported diagnosed diabetes among adults aged 20-79 increased
from 3.7% in 1980 to 8.3% in 2012, and the rapid increase was particularly prominent
between 1990-2008 (Geiss et al. 2014). When measured by either a diagnosis of
diabetes or HbA1c ≥ 6.5%, the prevalence among adults increased from 6.2% to 9.9%
between 1988-1994 and 2005-2010 (Selvin, et al., 2014). Despite these trends since the
1990s, a slowing, or even decreasing rate of growth of the diabetes epidemic has been
observed in recent national statistics; the estimated annual percentage change in rates
of the prevalence of diabetes reduced from 4.5% in 1990-2008 to 0.6% in 2009-2012
(Geiss et al., 2014). Many factors may contribute to this recent leveling off, such as
changes in diagnostic criteria for diabetes (Selvin & Ali, 2017) and improvements in
risk factor management (Menke et al., 2014).
Recent studies also show notable reductions in mortality rates among people with
diabetes. Age-standardized death rates in people with diabetes declined by 20% in every
10 years during 1985-2015 (from 23.1 to 15.2 per 1000 person-years) and such decrease
was largely attributable to the reduction in the number of deaths from vascular disease in
people with diabetes (Gregg et al., 2018). Another national study shows that
cardiovascular disease death rates among people with diabetes have dropped from 11.2 to
5.2 per 1000 person-years between 1988 and 2015 (Cheng et al., 2018). It has been also
found that the number of years of life lost due to diabetes has been reduced by 1.8 years
for men and 0.3 years for women at age 40 with self-reported diagnosed diabetes between
4

1985-1989 and 2000-2011 (Gregg, Zhuo, et al., 2014). These trends of reducing mortality
risk among people with diabetes result in a decrease in relative mortality risk between
people with and without diabetes. However, one study by Stokes and Mehta (2013)
reported that all-cause mortality rates among US adults aged 35-74 with prediabetes
(HbA1c levels between 5.7% and 6.4%) has increased from 11.19 to 14.02 per 1,000
person-years between 1988-2001 and 1999-2006 (Stokes & Mehta, 2013), suggesting that
changes in mortality risks could vary by types of diabetes.

1.2.2 Mortality and Race/Ethnicity
Despite substantial improvements in longevity for most Americans since the
1990s, significant racial/ethnic disparities in mortality have largely remained (Borrell &
Lancet, 2012). According to the National Center for Health Statistics (NCHS), life
expectancy at birth of the US population increased from 76.8 years to 78.8 years (from
74.1 years to 76.2 years for males and from 79.3 years to 81.0 years for females), but
racial gaps in life expectancy remained substantial; in 2016, life expectancy at birth was
78.5, 74.8 and 81.8 years for non-Hispanic Whites (Whites hereafter), non-Hispanic
Blacks (Blacks hereafter) and Hispanics, respectively. Thus, identifying and eliminating
the sources of mortality disparities by race/ethnicity has long been one of the primary
goals of public health interventions (Hummer, Rogers, Nam, & LeClere, 1999; National
Research Council. 2004).
To date, a variety of factors, from biological and individual factors to contextual
factors, have been proposed to explain racial disparities in mortality and longevity
5

(Williams & Sternthal, 2010). Among these factors, much attention has been paid to
overweight/obesity and smoking as many racial minorities commonly show higher
prevalence of these health indicators than Whites, and also these factors have been found
to be strongly associated with excess death (Cossrow & Falkner, 2004; Elo, Mehta, &
Preston, 2017; Ho & Elo, 2013). For instance, using data from the National Health and
Nutrition Examination Survey (NHANES), Elo, Preston and Mehta (2017) found that
different BMI distributions accounted for about 30% and 1% of Black-White difference
in mortality among women and men, respectively (Elo, Preston and Mehta, 2017).
Likewise, Ho and Elo (2013) reported that smoking accounted for approximately 23% of
Black-White difference in life expectancy among men at age 50 in 2005 (Ho & Elo,
2013). Despite a body of studies on smoking and BMI, relatively little is known about the
contribution of diabetes to the racial gap in mortality. What has been commonly done is
comparing the mortality risk of people with diabetes to that of people without diabetes by
race/ethnicity. Although such comparison provides information about the distribution of
diabetes-mortality patterns across race/ethnicity, this approach does not evaluate whether
and to what degree mortality gaps by race/ethnicity would be reduced if diabetes were
eliminated.

1.2.3 Diabetes and Race/Ethnicity
It is now well-documented that racial minorities have a higher prevalence of
diabetes compared to Whites. In 2013-2015, the age-adjusted prevalence of diagnosed
diabetes was estimated to be 12.7% among Black and 12.1% among Hispanic adults,
while Whites showed a significantly lower prevalence of 7.4% (Centers for Disease
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Control, 2017). The same pattern was observed with total diabetes, either having been
diagnosed with diabetes or have HbA1c levels ≥ 6.5%: among adults aged 20 or older,
the prevalence in 2015-2016 were 11.5%, 18.4% and 18.3% in Whites, Blacks and
Hispanics, respectively (Feng, 2018). The higher risk of diabetes in Blacks and Hispanics
than Whites is also evident by the lifetime risk of developing diabetes; the estimated
lifetime risks of diabetes at birth for males was found to be 26.7% among Whites, 40.2%
among Blacks and 45.4% among Hispanics (Narayan et al., 2003).
Many risk factors are associated with the observed higher diabetes prevalence
among racial minorities including higher prevalence of obesity, lower socioeconomic
status, poorer access to preventive care and physical inactivity among Blacks and
Hispanics. Among these factors, obesity/overweight has frequently been pointed out as a
major cause because the distribution of obesity/overweight has been found to be largely
paralleled with the distribution of diabetes across racial/ethnic groups, and the prevalence
of diabetes in recent years has increased simultaneously with an increase in obesity
among US adults (Hedderson et al., 2012). However, some studies have reported that
BMI is only marginally associated with racial disparities in diabetes. Brancati et al.
(1996), for instance, examined the role of SES and BMI and found that the Black-White
difference in diabetes prevalence was not explained by these two factors, and that Blacks
were over twice as more likely to have diabetes compared to Whites even after
controlling for SES and BMI (Brancati et al., 1996). On the other hand, several studies
have shown that racial disparities in diabetes vary by types of diabetes. When looking at
gestational diabetes, the age-adjusted prevalence was found to be higher among White
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women than African American women in the United States (Hedderson et al., 2012) In
addition, the incidence of type 1 diabetes was also higher among White (15.1 per 100,000
person-years) than Black (11.1) and Hispanic (12.1) youth aged 15-19 (Youth Study
Group et al., 2007). Other studies emphasized the importance of the country of origin.
Among Latinos, for instance, prevalence of diabetes was much higher for those from
Mexico, Puerto Rico and Central America than those from Cuba and South America
(Spanakis and Golden, 2013). Such variation is also found among Asian subpopulations
in the United States: Asian Indians showed the highest age-adjusted prevalence (14.2%)
and those from Korea (4.0%), Japan (4.9%) and China (6.2%) had relatively low
prevalence in 2004-2006 (Barnes et al., 2008).
Although Blacks and Hispanics show higher prevalence of diabetes compared to
Whites, it is not clear that mortality risk associated with diabetes is also higher for Blacks
and Hispanics than for Whites. Based on data from death certificates in 2016, the ageadjusted death rates from diabetes were 18.6% among Whites, 37.8% among Blacks and
25.7% among Hispanics, indicating the mortality rates for diabetic Blacks and Hispanics
are 2.03 and 1.38 times higher than those of diabetic Whites (Xu et al, 2018). However, a
randomized controlled study of 1,750 participants with type 2 diabetes and coronary
artery disease demonstrated that there were no significant mortality differentials between
Whites, Blacks and Hispanics during 5-years follow-up (Beohar et al., 2013). Also,
Conway et al. (2014) who investigated cause-specific mortality among low-income
Blacks and Whites aged 40-79 with type 2 diabetes found that Blacks had a lower risk of
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death from ischemic heart disease or respiratory disorders than Whites (Conway et al.,
2015).

1.2.4 Population Attributable Fraction of Diabetes
US national surveillance reports commonly use data from death certificates
collected from all localities across the United States to determine the frequency of total
deaths by causes of death. According to the National Vital Statistics Reports published
in 2018, there were 80,056 death certificates that mentioned diabetes as the underlying
cause of death, which accounted for approximately 2.9% of the total death
certifications in 2016 (Xu et al., 2018). The World Health Report 2003 also estimates
deaths by specific causes in WHO regions using the underlying cause. This report
shows that there were 987,000 deaths due to diabetes in 2002 and this number
accounted for 1.7% of the total deaths in the same year (WHO, 2003). Furthermore, the
National Center for Health Statistics (NCHS) produces years of life lost due to diabetes
by eliminating of deaths based on the underlying cause. According to the report, the
gain in life expectancy at age 30 is 0.34 years in 1999-2001 (Arias, Heron and TeledaVera, 2013). These estimates obtained based on death certificate data have been
frequently cited by researchers and policy makers to address the burden of diabetes on
the public health of the US population (McEwen et al., 2006).
However, scholars have consistently argued that the number of deaths attributable
to diabetes estimated based on death certificates could be seriously underreported. This is
because diabetes is often not considered as an underlying or contributing cause of death
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even though a decedent has diabetes (Murray et al., 2008; Saydah et al., 2004). Thus,
estimating deaths attributable to diabetes based on diabetes reported in a death certificate
fails to account for all decedents with diabetes, which leads to an underestimation of the
impact of the disease on a nation’s mortality.
Such limitation has been confirmed by numerous studies. These studies typically
calculate the proportion of individuals who were listed with diabetes as an underlying
cause of death on the death certificate among all individuals with diagnosed diabetes. For
instance, using NHANES 1971-1975, Gu (1988) found that only 36.0% of diabetic men
and 47.2% of diabetic women who died had diabetes listed anywhere on the death
certificate and the probability that diabetes is listed as the underlying cause is low,
ranging from 10% to 15% (Gu et al., 1998). Using 1986 National Mortality Followback
Survey, Bild and Stevenson (1991) also found very low sensitivity of death certificate
data; among 2,766 decedents with known diabetes, about 9.6% of deaths had diabetes as
the underlying cause of death on a death certificate (Bild & Stevenson, 1992). One study
by Saydah et al. (2004) that focuses on the assessment of diabetes measurement
summarized the sensitivity of underlying cause data reported in previous studies, and the
observed values range from 7.1% to 29.8%, suggesting that the frequency of recording of
diabetes on death certificates is considerably underreported to reflect the true impact of
diabetes (Murray et al., 2008; Saydah et al., 2004). The major problem of this
underestimation is the low reliability and validity of cause of death information on death
certificates and the large variation in interpreting and diagnosing primary causes of death
(McEwen et al., 2006). Another reason is that, in many cases, physicians who are
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required to complete a death certificate are not always able to identify whether a decedent
had diabetes at the time of death and thus whether diabetes is mentioned on a death
certificate is highly variable even though the decedent had diabetes.
One way of avoiding the limitation is to use the PAF. Using this approach, it is
possible to quantify a contribution of a risk factor to total deaths in a population based on
survey data in which people’s diabetes status can be identified before death. Although
defined in various ways, in general, PAF is defined as the proportional reduction in
deaths, or a disease risk, in a specific time period if a risk factor were eliminated or
reduced to a hypothetical level over a specific time period (Rockhill, Newman, &
Weinberg, 1998; Smith, Schellenberg, & Hayes, 1994).
The PAF has been employed in many studies of diabetes. For example, Roglic
et al. (2005) estimated the number of deaths attributable to diabetes in African,
American, Eastern Mediterranean, European Southeast Asia and Western Pacific
regions in 2000 (Roglic et al., 2005). Roglic et al. reported that the fraction of global
mortality that is attributable to diabetes is 5.2% (2.9 million deaths) and the fraction is
higher in North America (8.5%) and Middle East (9%) than the poorest African
countries (2.4%). Alva et al. (2018) applied the PAF approach to estimate state-level
diabetes-attributable mortality from all causes and from causes specific to
cardiovascular diseases using the Behavioral Risk Factor Surveillance System and the
NHIS 2005-2009 and LMF through 2011. Results from their analyses showed that the
number of excess deaths attributable to diabetes in 2013 were 156,000 and 137,000
deaths in men and women, respectively. These values were combined to account for
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11% of the total deaths in the year 2013, which is almost four times the estimates when
diabetes is listed as the underlying cause (Alva et al., 2018). Stokes and Preston (2017)
also estimated the fraction of deaths attributable to diabetes in the US population ages
30-84 using a nationally representative sample. In their study, the attributable fraction
of total deaths due to diabetes was about 11.8%, which is much greater than a value of
3.4% based on death certificates as the underlying cause of death (Stokes & Preston,
2017). The PAF has been also used for smoking and overweight/obese (Mehta &
Chang, 2009; Ho & Elo, 2013; Preston, Glei, & Wilmoth, 2010). For instance, Ho and
Elo (2013) found that smoking is responsible for 33.1% of deaths of black men and
29.7% of deaths of white men aged 50 to 84 in the 1997-2003 survey cohorts. A
similar method was applied to BMI analysis; Mehta and Chang (2009) found that class
Ⅱ/Ⅲ (BMI ≥ 35.0) is responsible for 3-4% of all deaths among people ages 50-61 in
1992-2004 in the US.
One limitation of the previous literature of diabetes is that previous studies do not
estimate the contribution of diabetes to the national mortality by age, sex and
race/ethnicity. Due to this limitation, it is still unclear whether the impact of diabetes to
mortality varies by age groups, sex and race/ethnicity. In addition, little is known about
whether and to what extent eliminating diabetes reduces mortality disparities between
sexes and racial/ethnic groups. Prior studies have shown that, however, age, sex and
race/ethnicity are important risk factors for diabetes, and there is a large variation in
diabetes rates by these three factors (Davidson & Schriger, 2010; Fishman, Stokes, &
Preston, 2014).
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1.3 Aims of Chapter 1
The aims of this chapter are threefold. First, I will estimate age-specific PAFs due
to diabetes separately by sex and race/ethnicity. Second, using estimated PAF values, I
will estimate the contribution of diabetes to life expectancy by sex and race/ethnicity.
Third, I will compare these estimates based on PAFs to values calculated based on the
underlying cause of death data.

1.4 Data and Methods

1.4.1 Data and Sample
Two data sources are used in this chapter: the public use 1997-2009 National
Health Interview Survey and Linked Mortality Files (NHIS-LMF) and the official
2010 US life tables for the entire US population and by sex and race/ethnicity. NHIS is
a nationally representative, cross-sectional survey of the non-institutionalized
population in the United States. The NCHS has linked respondents in NHIS to death
certificate records in the National Death Index (NDI). Adults who are eligible for the
linkage were followed up from the survey date through December 31, 2011 (National
Center for Health Statistics 2016). The second data are drawn from 2010 US life
tables. In the life tables, age and sex specific mortality rates are presented for Whites,
Blacks and Hispanics. Using these rates in combination with estimates of age-sexrace/ethnicity specific PAFs allows the estimation of gains in life expectancy without
diabetes separately by sex and race/ethnicity.
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To estimate hazard of death associated with diabetes, I fitted Cox proportional
hazard regression models with duration since baseline as exposure time using data
from the 1997-2009 NHIS-LMF. The outcome was death from all causes during the
follow-up period. The analysis of this chapter was limited to adults aged 30 and older.
Among 294,936 adults, 7,856 (or 2.7%) were excluded from analyses due to missing
information on covariates. In addition, those with less than one quarter-year of followup were also excluded (n=270), yielding a final sample of 286,810 adults. I limited
follow-up to a maximum of 5 years following the survey date in order to reduce the
possible bias that individuals were diagnosed with diabetes after they were surveyed.
Proportional hazards assumption was tested based on the slope of the Schoenfeld
residuals for the model.

1.4.2 Variable Definitions
Diabetes was identified based on self-reported diagnosed diabetes in the NHIS.
During the interview, NHIS respondents were asked “Other than during pregnancy,
have you ever been told by a doctor or health professional that you have diabetes or
sugar diabetes.” If answered “yes” to the question, I assigned them as diabetic. Those
who answered “no” or “borderline diabetes” were considered as non-diabetic. Other
covariates include age, gender, race/ethnicity, educational attainment, and smoking.
Age is baseline age at the survey. Race/ethnicity was constructed by self-reported
identification and categorized as non-Hispanic Whites (reference category), nonHispanic Blacks, Hispanics and other racial/ethnic groups. Education was categorized
into four groups: less than 9th grade, 9th – 11th grade, high school graduate (reference
14

category), some college and 4 years of college degree or higher. Smoking was
categorized as never (reference category), former smoker and current smoker.
Respondents were asked whether they had ever smoked 100 cigarettes in their entire
lifetime. If they reported “no” to the question, I assigned them as never smoker. If they
said “yes” to the question, but were currently not smoking, they were considered
former smokers. Current smokers are those who reported that they are currently
smoking. Drinking is categorized as never drinker, former drinker and current drinker.
Former drinkers are those who did not drink during the past year, but had more than
100 drinks in lifetime. Current drinkers are people who had more than one drink in the
past year. Hypertension is self-reported, constructed using a survey question asking
whether respondents were diagnosed with hypertension or high blood pressure by a
doctor or other health care professional.

1.4.3 Statistical Approach
To estimate the risk of death associated with diabetes, three Cox Proportional
models were used. In the first model, all covariates- race/ethnicity, self-reported
diagnosed diabetes, age at baseline, male, education, smoking, drinking and
hypertension- are adjusted for (Model 1). In Model 2, interactions between age at
baseline and diabetes as well as between male and diabetes were additionally included,
and race/ethnicity was dropped (Model 2). These variables in Model 2 are used to
calculate age-specific hazard ratios for males and females, all racial and ethnic groups
combined for 5-year age groups. Model 3 includes all variables in Model 2,
race/ethnicity and interactions between diabetes and race/ethnicity. Based on results
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from Model 3, age-sex-race/ethnicity specific hazard ratios associated with diabetes
were calculated for 5-year age groups. For age category x to x+5, age of x+2.5 was
used in the calculation of hazard ratios and 87.5 was used for the age group of 85+,
that is the top age code in the NHIS.
The prevalence of diabetes among deaths in each age-sex-race/ethnicity group
was obtained from the 5-year follow-up in NHIS. The prevalence for age interval x to
x+5 was based on the 5-year follow-up for cohorts aged x-5 to x+ 5 at baseline, a
group whose exposure was centered on the age interval x to x+5. For instance, the
prevalence in age interval 40-45 was calculated based on the number of individuals
aged 35-45 at baseline and the number of deaths among them during the 5-year followup. The PAF is defined as a function of the hazard ratio of death associated with
diabetes and the prevalence of diabetes among those who died during the follow-up
period:

where pdi is the proportion of deaths occurring to those in exposure category i
based on age, sex and race/ethnicity and HRi is the hazard ratio of death for an
individual in the ith exposure category. The PAF values used in this chapter were
estimated separately in 5-year wide age intervals. I assumed that the prevalence of
diabetes among deaths for age intervals above 85 was constant and equal to the
prevalence for the age category 85+. Life expectancy after eliminating deaths from
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diabetes was calculated from an associated single decrement life table for all causes
other than diabetes (Preston, Heuveline, & Guillot, 2001). To do this, I first calculated
age-sex-race/ethnicity specific PAF values based on corresponding hazard ratios and
prevalence of diabetes among decedents obtained from the previous stages. Then, the
proportion of deaths attributable to diabetes was eliminated from the 2010 US life
tables at each age using the PAF values. Based on newly obtained age-sexrace/ethnicity specific mortality rates in the life table, I reconstructed the life table
using age-specific death rates without diabetes and calculated age-specific life
expectancy.
As discussed previously, the conventional way of estimating the impact of
diabetes is to use an underlying cause of death. Because NHIS-LMF include
information on underlying causes of death, it is possible to calculate the probability of
dying without diabetes. Using this information, I then estimated life tables by sex and
race/ethnicity without diabetes. I then compared these results to those based on the
PAF approach (Table 1-7).
Data analyses were performed using Stata version 15 (StataCorp, Texas, USA).
All analyses incorporated sample weights and accounted for the complex design of the
survey. Standard errors were estimated using the SVY routine.
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1.4.4 Sensitivity Analysis
After the primary analyses, I conducted multiple sensitivity analyses. For one, I
estimated Cox Proportional regression models in which hypertension and drinking
behaviors were omitted to assess the influence of these risk factors on the association
between diabetes and mortality. In addition, I adjusted for BMI, a major risk factor for
the development of diabetes to assess the effect of BMI on the prior results. In the
main analysis, BMI was not considered due to the “obesity paradox,” which is the
phenomenon that people with overweight/obese show lower mortality risk than those
with normal weight when they have diabetes (Preston and Stokes, 2014). In a second
sensitivity analysis, the 2005 official US life tables, instead of the 2010 life tables,
were applied in to assess a potential bias derived from the selection of the year 2010
for the US life tables.

1.5 Results
1.5.1 Descriptive Analysis
Table 1-1 presents the demographic characteristics of the sample by sex and
race/ethnicity. 286,810 individuals were included in analyses contributing a total of
1,311,397 person-years. Compared to Whites, Blacks had higher and Hispanics had
lower age-standardized death rates. Overall, death rates in participants with selfreported diagnosed diabetes were higher than those of individuals without self-reported
diabetes, but these differences were inconsistent across racial/ethnic groups. Overall,
the prevalence of diagnosed diabetes in the sample was 8.9% among men and 8.4%
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among women. As expected, Blacks and Hispanics had a higher prevalence of
diagnosed diabetes than Whites for both men and women, which is consistent with the
previous estimates from national statistics (CDC, 2017).

1.5.2 Results from Cox Proportional Hazard Models
Table 1-2 provides results from Cox Proportional hazards models. In Model 1,
all covariates are adjusted for. As expected, Blacks (HR:1.141, 95% CI:1.086-1.199)
had significantly higher hazard and Hispanics (HR:0.808, 95% CI:0.756-0.865) had
lower hazard of death than Whites. Having diagnosed diabetes was significantly
associated with mortality (HR:1.597, 95% CI:1.529-1.668). In addition, age, male,
lower education, former and current smoking behavior and self-reported hypertension
were significantly associated with a higher risk death.
Model 2 additionally includes interactions between diabetes and age, and
diabetes and male and drops race/ethnicity. The interaction between diabetes and age
was significant (HR: 0.981, 95% CI: 0.977-0.985), implying that the risk associated
with diabetes was reduced by a factor of 0.981 for each additional year of age beyond
age 30. In addition, the interaction between diabetes and male was also significant
(HR:0.889, 95% CI: 0.816-0.969), indicating that hazard of death for diabetic men was
lower than that of diabetic women by a factor of 0.889.
Model 3 introduces race/ethnicity and interaction terms between race/ethnicity
and diagnosed diabetes. The interaction terms were significant for both Blacks
(HR:0.793, 95% CI:0.697-0.902) and Hispanics (HR:0.828, 95% CI:0.711-0.963) and
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hazard ratios of the interactions were less than 1. That is, the effect of diagnosed
diabetes on all-cause mortality for Blacks and Hispanics were significantly weaker
than that for Whites. Using the hazard ratios from Model 2 and 3, age-specific hazard
ratios by sex and race/ethnicity were calculated and presented in Table 1-3. For
example, a 50-year-old Black woman had a hazard ratio of 4.205*0.793*(.980)22.5 =
2.450.

1.5.3 The Prevalence of Diabetes among Deaths
The prevalence of self-reported diagnosed diabetes among deaths is presented
in Table 1-4 and graphically in Figure 1-1A. The overall prevalence among decedents
is 22.8% among men and 22.5% among women, and these values are much higher than
the prevalence of diabetes among the overall sample (8.9% among men and 8.4%
among women). Figure 1-1A reveals a hill-shaped pattern for both sexes and three
racial groups. In general, the prevalence increases rapidly with advancing age from age
30-35 and then decreases sharply after ages around 75-79. There were little differences
in the prevalence across race/ethnicity until ages 40-44 for both men and women, but
then Blacks and Hispanics showed much higher prevalence than Whites. The racial
gaps at older ages were greater among women than men: the prevalence at the age
interval 65-69 were 27.0%, 29.4% and 36.4% for White, Black and Hispanic men,
respectively, but for women the corresponding values were 26.5%, 43.5% and 51.1%.
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1.5.4 Population Attributable Fraction
Using age-specific hazards presented in Table 1-3 and prevalence of diabetes
among decedents shown in Table 1-4, age-sex-race/ethnicity specific PAF values were
calculated following the formula presented on page 16. Estimated PAF values are
presented numerically in Table 1-5 and graphically in Figure 1-1B. Most importantly,
three racial and ethnic groups had similar PAFs across ages. Such little variation is a
product of lower hazard ratios for Blacks and Hispanics and their higher prevalence
among deaths. For example, the ratio of White prevalence to Black prevalence among
men in the age interval 55-59 is 0.71 (22.6/31.7), but the corresponding value for
hazard ratios is 1.25 (2.117/1.697), resulting in a similar PAF for White (11.9%) and
Black (12.8%) men at age 55-59 (Table 1-5). There were larger differences in the PAF
values among women than men at older ages. This is because the observed excess
prevalence of diabetes among Blacks and Hispanics compared with Whites was more
prominent among women than men (Table 1-4 and Figure 1-1A).

1.5.5 Gains in Life Expectancy from Eliminating Deaths from Diabetes
Table 1-6 exhibits the gains in life expectancy at ages 30, 50 and 70 eliminating
deaths attributable to diabetes using PAF and underlying cause of death. Based on the
official 2010 US life table, life expectancy at age 30 in 2010 was 47.8 years for men
and 52.0 years for women. Eliminating deaths attributable to diagnosed diabetes at
each age interval increases life expectancy at 30 by 0.83 years for men and by 0.89
years for women all racial combined. Hispanics have the smallest gain in life
expectancy in both men (0.65 years) and women (0.80 years) at age 30 because they
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have relatively lower death rates in the life tables especially at older ages in which
PAF values are relatively high. Similar to PAF values presented in Table 1-4, I
observed little differences in the gains in life expectancy by race/ethnicity in both
sexes. This result is a product of the offsetting effects of higher prevalence of
diagnosed diabetes among Black and Hispanic decedents and their lower hazard ratios
associated with diabetes.
Table 1-7 presents comparisons of gains in life expectancy and probability of
dying at age 30 based on PAF and underlying cause of death. The gain in life
expectancy for each sex from eliminating diabetes as an underlying cause of death was
0.33 years at age 30, which is only about one third of the gain estimated based on
PAFs. The value of 0.33 years is similar to a previous finding of 0.31 years of gain at
age 30 in 1999-2001 reported by the NCHS (Arias, Heron and Teleda-Vera 2013).
Similar patterns were present in the probability of dying from diabetes. At age 30, the
probabilities were 0.055 for men and 0.062 for women per 1,000 persons when PAF
values were applied, but the values were about a half for both sexes when based on
underlying cause of death. Hispanic males and females show comparable gains in the
life expectancy and higher probability of dying from diabetes based on underlying
cause of death compared to estimated values based on PAF. For instance, the gain in
life expectancy among Hispanic females based on PAF and underlying cause of death
were the same at 0.80. In addition, with respect to probability of dying, the observed
value based on an underlying cause of death is even higher than the probability of
dying based on PAF among Hispanic males (0.050 vs 0.036) and females (0.070 vs
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0.050) at age 30. This implies that diabetes is more likely to be assigned as the
underlying cause on a death certificate of Hispanic decedents than other racial groups
(Pandney et al. 2001).

1.5.6 Results from the Sensitivity Analyses
I conducted several sensitivity analyses as explained previously. First, when
hypertension and drinking behaviors were dropped from the Cox proportional hazard
models, the hazard ratio of diabetes increased and, in turn, gains in life expectancy
without diabetes at age 30 rose from 0.83 years to 0.87 years for men and from 0.89
years to 0.94 years for women. When BMI was included in Model 3 gains in life
expectancy also increased at age 30 to 0.88 years for men and 0.98 years for women.
These changes suggest that model specification affects the magnitude of the
coefficients, but it does not seriously alter the interpretation of the results. In the
second sensitivity analysis, I used the 2005 US official life table, instead of the 2010
life table, and this transition slightly increased the estimated gain in life expectancy at
age 30 by 0.02 years for both men and women because of higher age-specific mortality
rates in the year 2005 compared to 2010.

1.6 Discussion
This chapter investigates the effect of diabetes on US life expectancy by
applying age-sex-race/ethnicity specific PAFs to the 2010 US life tables. The
elimination of deaths attributable to diabetes from the life table results in an increase of
life expectancy by 0.83 years for men and 0.89 years for women at age 30. When
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deaths listed diabetes as the underlying cause of death were deleted in the same
fashion, the gain in life expectancy was only 0.33 years at age 30 (Table 1-7). The
underestimation based on death certificates observed in this chapter is consistent with
previous findings (Alegre-Díaz et al., 2016; Roglic et al., 2005; Stokes & Preston,
2017). The overall PAF value in the sample was 7.2% for men and 8.4% for women
aged 30 and over (Table 1-5). These values are slightly lower than the PAFs reported
by Stokes and Preston (2017), which is 10.6% for men and 12.5% for women aged 3084, because this chapter includes ages 85 + and PAF values are found to decrease at
older ages. Also, the estimated PAF values are higher than the probability of dying
from diabetes (5.5% for men and 6.2% for women, Table 1-7), although both estimated
PAF values and probability of dying are calculated based on the same set of agespecific PAFs. The difference between two values are from difference in the age
distribution of deaths between the US population and life table; the former is younger
than the latter.
Table 1-5 shows that three racial/ethnic groups have similar age-sex specific
PAF values. The little variations in the distribution of age-specific PAFs are a product
of higher prevalence of diabetes among Black and Hispanic decedents and lower
hazard associated with diabetes for these groups compared to Whites. The lower
hazard for racial minorities with diabetes than Whites are found in several studies that
investigated all-cause and cause specific mortality (Conway et al., 2015; Conway, May,
& Blot, 2012). However, questions remain why Blacks and Hispanics have lower
hazard associated with diabetes. One possible explanation is that Blacks and Hispanics
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who were diagnosed with diabetes may have a less severe case than Whites which led
the racial minority groups to have lower risk of death than Whites when they have
diabetes. This possibility was tested using the National Health and Nutrition
Examination Survey (NHANES) 1999-2013 which has biomarker information for
diabetes, such as glycated Hemoglobin (HbA1c). An analysis of HbA1c by
race/ethnicity among NHANES adults ages 30 and over with self-reported diagnosed
diabetes shows that the mean HbA1c is higher for Blacks and Hispanics than Whites,
suggesting that this possibility is not the case. A second possibility is potential racial
disparities in average glucose levels at a given HbA1c level. Previous studies reported
that racial minorities tend to have lower fasting plasma glucose or 2-hr glucose levels
than Whites at a given HbA1c (Wolffenbuttel et al., 2013; Ziemer et al., 2010). Thus,
Blacks and Hispanics with self-reported diagnosed diabetes could have lower FPG or
2-hr glucose than Whites (Davidson & Schriger, 2010; Guo et al., 2014) and therefore
Blacks and Hispanics with diabetes could be at a lower risk of death due to lower
glucose concentration than Whites with diabetes. A third explanation pertains to the
relation between diabetes and mortality. The analysis of the current chapter is based on
Cox Proportional hazard model that assumes that the relative risk of death from being
diabetic is multiplicative rather than additive. However, the relationship could be
additive rather than multiplicative (Mehta & Preston, 2016). If the relation is additive,
Blacks who experience higher risk of death from other causes would have a higher
absolute increase in mortality when being diagnosed with diabetes than Whites and
Hispanics with diagnosed diabetes. However, Table 1-1 shows an opposite pattern;
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Blacks showed a lower absolute increase in mortality with regard to being diabetic
than Whites.
This chapter has several limitations. First, identifying diabetes based on selfreported diagnosed diabetes may not capture undiagnosed cases. However, a prior
study reported that self-reported diabetes shows high sensitivity and specificity in
detecting people with diabetes (Saydah et al., 2004). In addition, one paper that
employed both a HbA1c measurement of 6.5% and self-reported diabetes in Cox
proportional models reported very similar hazard ratios of death associated with
diabetes for the two indicators (Stokes and Preston, 2017). Therefore, it is unlikely that
the use of self-reports significantly affects the validity of the results. Second, the NHIS
linked-mortality files do not include information on diabetes status during follow-up
and it is possible that participants were diagnosed with diabetes during the follow-up
period which could underestimate the impact of diabetes on mortality. To minimize
this potential bias, all analyses were limited to the maximum of 5 years of follow-up
beyond the survey. Lastly, this study pooled surveys from 1997 to 2009, nearly a
decade, to increase sample size. Given considerable changes in the demographic
composition of the US population and the prevalence of diabetes and mortality risks in
people with and without diabetes during the last decade, it is possible that PAF values
would be fluctuating during the period. However, secular changes in PAFs due to
diabetes were not systematically tested in this study due to a small sample size.
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TABLES
Table 1-1. Sample Characteristics by Race/Ethnicity, Ages 30 and Above, NHIS-LMF 1997-2009
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Death rateb
Among diabeticb
Among non-diabeticb
Diabetes prevalence (%)
Mean age (years)
Age categories (%)
30-44
45-64
65 and over
Education
Less than 9th grade
9th – 11th grade
High school graduate
Some college
4 Yrs college +
Smoking
Never smoker
Former smoker
Current smoker
Alcohol status
Never drinker
Former drinker
Current drinker
Hypertension (% Yes)
Number of deathsc
Person-yearsc
Unweighted N
a

All Racesa
Men
Women
19.2
12.2
29.8
21.3
17.6
11.0
8.9
8.4
50.7
52.2

Non- Hispanic White
Men
Women
18.8
11.9
31.2
22.4
17.3
10.8
8.3
7.4
51.9
53.4

Non- Hispanic Black
Men
Women
23.6
15.6
31.3
22.1
22.4
13.8
11.9
13.5
48.6
49.8

Hispanic
Men
Women
17.4
10.4
25.2
17.8
15.5
8.7
9.9
10.4
45.9
47.5

39.7
41.6
18.7

37.0
40.3
22.7

36.4
42.9
20.8

33.8
41.1
25.1

45.3
40.6
14.1

42.9
39.7
17.4

55.1
34.3
10.6

50.3
35.7
14.0

7.0
7.6
30.8
25.7
29.0

6.7
8.0
32.8
28.0
24.5

4.1
6.5
31.2
26.5
31.7

3.9
6.7
33.8
29.0
26.5

7.3
11.5
36.4
27.8
17.0

6.3
13.0
33.6
30.2
16.9

27.5
12.9
27.3
19.6
12.7

27.2
12.9
27.5
20.3
12.1

45.6
31.0
23.4

59.4
21.6
19.0

43.1
33.7
23.2

55.2
24.6
20.2

50.0
21.9
28.2

65.0
14.5
20.5

55.0
23.7
21.3

76.2
12.2
11.7

13.1
18.0
68.8
30.7
8,759
565,675
124,272

27.7
16.7
55.6
31.7
9,440
745,722
162,538

11.0
18.2
70.8
31.4
6,501
389,327
85,367

22.3
17.0
60.7
31.0
7,080
496,118
107,956

19.8
21.0
59.2
37.1
1,237
68,274
15,215

38.6
19.6
41.8
43.8
1,458
110,793
24,351

16.6
15.8
67.5
21.1
839
85,425
18,617

45.8
13.1
41.1
26.0
726
112,159
24,258

All races include other racial/ethnic groups that are not separately identified.
Age-standardized rates per 1,000 person-years using 2010 US population age distribution as the standard for both sexes. Source: 2010 US Census.
c
Individuals in the sample are followed up to five years following the interview.
b

Table 1-2. Hazard Ratios from the Cox Proportional Hazard Model Predicting All-Cause Mortality, Ages 30 and Above,
NHIS-LMF 1997-2011
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Model 1
95% CI
Model 2
95% CI
Race/Ethnicitya
Non-Hispanic White (ref)
1.000
Non-Hispanic Black
1.141
[1.086-1.199]
Hispanic
0.808
[0.756-0.865]
Diabetes
1.597
[1.529-1.668]
3.807
[3.170-4.574]
Age (in years since age 30)
1.093
[1.091-1.095]
1.097
[1.095-1.099]
Male
1.488
[1.435-1.542]
1.519
[1.458-1.582]
Education
Less than 9th grade
1.229
[1.166-1.295]
1.200
[1.142-1.263]
9th – 11th grade
1.211
[1.147-1.278]
1.215
[1.152-1.282]
High school graduate (ref)
1.000
1.000
Some college
0.931
[0.886-0.979]
0.931
[0.886-0.979]
4 yrs college +
0.783
[0.738-0.830]
0.782
[0.738-0.829]
Smoking
Never smoker (ref)
1.000
1.000
Former smoker
1.421
[1.364-1.482]
1.428
[1.370-1.488]
Current smoker
2.501
[2.374-2.636]
2.525
[2.340-2.661]
Drinking status
Never drinker (ref)
1.000
1.000
Former drinker
1.036
[0.989-1.086]
1.046
[0.998-1.010]
Current drinker
0.710
[0.678-0.744]
0.716
[0.684-0.750]
Hypertension
1.190
[1.146-1.237]
1.189
[1.145-1.234]
Interactions with diabetesa
Diabetes X Age (in years since age 30)
0.981
[0.977-0.985]
Diabetes X Male
0.889
[0.816-0.969]
Diabetes X Non-Hispanic Black
Diabetes X Hispanic
ref: Reference group.
a
“Other racial groups” are separately identified in Models 1 and 3, but results for this group are not shown.

Model 3
1.000
1.217
0.848
4.205
1.097
1.523
1.235
1.210
1.000
0.932
0.788

95% CI

[1.146-1.291]
[0.785-0.916]
[3.483-5.076]
[1.095-1.099]
[1.462-1.587]
[1.172-1.300]
[1.147-1.278]
[0.887-0.980]
[0.743-0.835]

1.000
1.419
2.492

[1.361-1.479]
[2.365-2.623]

1.000
1.037
0.715
1.177

[0.989-1.087]
[0.683-0.749]
[1.133-1.223]

0.980
0.889
0.793
0.828

[0.976-0.983]
[0.815-0.969]
[0.697-0.902]
[0.711-0.963]

Table 1-3. Age-specific Hazard Ratios Associated with Diabetes, Ages 30 and Above, NHIS-LMF 1997-2011
Age
All Races a
Non-Hispanic White
Non-Hispanic Black
Hispanic
Interval
Menb
Womenb
Menc
Womenc
Menc
Womenc
Menc
Womenc
30 – 34
3.224
3.625
3.549
3.993
2.815
3.167
2.938
3.306
35 – 39
2.923
3.287
3.201
3.601
2.538
2.856
2.650
2.981
40 – 44
2.650
2.980
2.886
3.248
2.289
2.576
2.390
2.689
45 – 49
2.403
2.702
2.603
2.929
2.064
2.323
2.155
2.425
50 – 54
2.179
2.450
2.348
2.641
1.862
2.095
1.943
2.187
55 – 59
1.975
2.221
2.117
2.382
1.679
1.889
1.753
1.972
60 – 64
1.791
2.014
1.909
2.148
1.514
1.704
1.581
1.778
65 – 69
1.624
1.826
1.722
1.937
1.366
1.536
1.425
1.604
70 – 74
1.472
1.655
1.553
1.747
1.231
1.386
1.285
1.446
75 – 79
1.335
1.501
1.400
1.576
1.111
1.250
1.159
1.304
80 – 84
1.210
1.361
1.263
1.421
1.002
1.127
1.045
1.176
85 +
1.097
1.234
1.139
1.281
1.000
1.016
1.000
1.061
a
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All races include other racial/ethnic groups that are not separately identified.
Hazard ratios are from Model 2 in Table 1-2.
c
Hazard ratios are from Model 3 in Table 1-2.
Age-specific hazard ratio is set to 1.000 if the value is lower than 1.000.
In calculating age-specific hazard ratios, we used more decimal places than shown in Table 1-2.
b
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Table 1-4. Prevalence of Diabetes (Percent) among Deaths, Ages 30 and Above, NHIS-LMF 1997-2011
Age
All Racesa
Non-Hispanic White
Non-Hispanic Black
Interval
Men
Women
Men
Women
Men
Women
30 – 34
2.5
3.9
4.0
6.4
1.9
1.3
35 – 39
5.7
7.2
6.8
9.0
7.4
7.0
40 – 44
10.3
9.6
9.0
11.0
18.5
7.9
45 – 49
13.4
12.4
11.7
13.6
17.0
10.5
50 – 54
17.8
20.0
15.2
19.7
24.6
23.4
55 – 59
24.4
26.5
22.6
23.5
31.7
36.8
60 – 64
28.7
28.4
28.0
23.8
31.2
39.4
65 – 69
27.9
30.8
27.0
26.5
29.4
43.5
70 – 74
27.2
30.1
26.0
26.7
28.3
44.8
75 – 79
26.5
26.6
25.4
23.9
29.5
42.8
80 – 84
22.8
22.0
21.8
19.4
27.1
38.8
85 +
17.6
14.8
17.2
13.2
18.8
26.3

Men
0.0
1.3
6.4
16.1
20.1
25.9
36.6
36.4
34.8
37.1
35.3
27.7

Women
0.0
2.4
8.8
13.1
15.9
32.8
47.9
51.0
41.3
31.1
31.8
28.4

Ages 30+

27.2

31.0

a

22.8

22.5

22.0

All races include other racial/ethnic groups that are not separately identified.
The complex NHIS survey design is taken into account.

20.1

26.0

33.7

Hispanic

Table 1-5. Percentage of Deaths Attributable to Diabetes (PAF), Ages 30 and Above, NHIS-LMF 1997-2011
Age
All Racesa
Non-Hispanic White
Non-Hispanic Black
Hispanic
Interval
Men
Women
Men
Women
Men
Women
Men
Women
30 – 34
1.7
2.8
2.9
4.8
1.2
0.9
0.0
0.0
35 – 39
3.8
5.0
4.7
6.5
4.5
4.6
0.8
1.6
40 – 44
6.4
6.4
5.9
7.6
10.4
4.8
3.7
5.5
45 – 49
7.8
7.8
7.2
8.9
8.7
6.0
8.6
7.7
50 – 54
9.6
11.8
8.8
12.2
11.4
12.2
9.8
8.6
55 – 59
12.0
14.6
11.9
13.6
12.8
17.3
11.1
16.2
60 – 64
12.7
14.3
13.3
12.7
10.6
16.3
13.4
21.0
65 – 69
10.7
13.9
11.3
12.8
7.9
15.2
10.9
19.2
70 – 74
8.7
11.9
9.3
11.4
5.3
12.5
7.7
12.8
75 – 79
6.7
8.9
7.3
8.7
2.9
8.5
5.1
7.3
80 – 84
4.0
5.8
4.5
5.8
0.0
4.4
1.5
4.8
85 +
1.6
2.8
2.1
2.9
0.0
0.4
0.0
1.6
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Ages 30+
a

7.2

8.4

7.4

8.0

6.6

9.4

6.7

9.5

All races include other racial/ethnic groups that are not separately identified.
We use age-specific hazard ratios (Table 1-3) and prevalence of diabetes among deaths (Table 1-4) with more decimal places than presented in tables.

Table 1-6. Life Expectancy at Ages 30, 50 and 70 in the 2010 US Life Table and Gains in Life Expectancy from Eliminating
Deaths Attributable to Diabetes
2010 US Life Tablea
Gain in Life Expectancy from Eliminating Diabetes
All
NHW
NHB
Hispanic
All
NHW
NHB
Hispanic
Men
Men
30
47.8
48.0
44.3
50.0
0.83
0.85
0.81
0.65
50
29.6
29.7
26.6
31.4
0.77
0.80
0.70
0.61
70
14.2
14.2
12.9
15.4
0.36
0.39
0.17
0.23
Women
Women
30
52.0
52.2
49.5
54.6
0.89
0.85
1.05
0.80
50
33.2
33.3
31.2
35.4
0.84
0.79
1.02
0.77
70
16.4
16.5
15.8
18.0
0.47
0.46
0.44
0.37
a

Source: National Center for Health Statistics (2014).
All: All racial/ethnic groups, NHW: non-Hispanic White, NHB: non-Hispanic Black.

32

Table 1-7. Comparison of Gains in Life Expectancy from Eliminating Diabetes and Probability of Dying from Diabetes at Age
30: Population Attributable Fraction versus Underlying Cause of Death Calculations
Life Years Lost to Diabetes Using PAF
Life Years Lost to Diabetes Using Underlying
Cause of Death
All
NHW
NHB
Hispanic
All
NHW
NHB
Hispanic
Males
0.83
0.85
0.81
0.65
0.33
0.30
0.44
0.58
Females
0.89
0.85
1.05
0.80
0.33
0.23
0.68
0.80
Probability of Dying from Diabetes
Probability of Dying from Diabetes
using PAF
Using Underlying Cause of Death
Males
0.055
0.059
0.044
0.036
0.027
0.025
0.033
0.050
Females
0.062
0.061
0.060
0.050
0.028
0.022
0.053
0.070
All: all racial/ethnic groups, NHW: non-Hispanic White, NHB: non-Hispanic Black
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FIGURES

34
Figure 1-1. Prevalence of Diagnosed Diabetes among Deaths (Figure 1A) and Proportion of Deaths Attributable to Diabetes
(PAF) (Figure 1B) by Sex and Race/Ethnicity at Ages 30 and Above, 1997-2011 NHIS-LMF.
Age in the x-axis is the age at baseline.

CHAPTER 2

THE EFFECT OF MEASURED AND DIAGNOSED
DIABETES ON MORTALITY IN THE UNITED STATES

Abstract
Background: A strong association between diabetes and mortality is increasingly
evident. Prior studies often ignored differences between self-reported diagnosed diabetes
(self-reported diabetes) and biomarkers for diabetes measured at the start of the mortality
follow-up (or at baseline). This chapter examines the mortality risks based on selfreported diabetes and baseline HbA1c levels simultaneously.
Data and Methods: Data are from the National Health and Nutrition Examination
Survey (NHANES) 3 (1988-1994) and continuous NHANES 1999-2014, and Linked
Mortality Files through December 2015. The NHANES sample adults ages 30-84
(n=40,103) are categorized by a baseline HbA1c cutoff point of 6.5% and further by selfreported diabetes, resulting in four diabetes groups: HbA1c < 6.5% and without selfreported diabetes (no diabetes); HbA1c < 6.5% and with self-reported diabetes
(controlled diabetes); HbA1c ≥ 6.5% without self-reported diabetes (undiagnosed
diabetes); and HbA1c ≥ 6.5% and with self-reported diabetes (uncontrolled diabetes).
Relative mortality risks among these four diabetes statuses are estimated using RoystonParmar survival models.
Results: Results from survival models show that self-reported diabetes has a stronger
association with mortality than baseline HbA1c. In all models, adults with self-reported
diabetes (either controlled diabetes or uncontrolled diabetes) have a higher mortality risk
than adults without self-reported diabetes (either no diabetes or undiagnosed diabetes).
Thus, the results show that adults with self-reported diabetes have a higher risk of death
than those without self-reported diabetes, regardless of their diabetes status identified by
baseline HbAlc.
Conclusion: When considered simultaneously, self-reported diabetes shows a stronger
predictive power for mortality than baseline HbA1c. Therefore, public health
interventions for diabetes prevention should focus on people who at a risk of developing
diabetes and those whose HbA1c level indicates prediabetes and those with diabetes
regardless of their HbA1c level.
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2.1 Introduction
Diabetes mellitus is one of the leading causes of death and public health threats
in the United States. Previous evidence has consistently shown that people with
diabetes/prediabetes have higher risks of a wide range of complications, including
cardiovascular diseases, cancer, stroke, acute myocardial infarction, major amputations
and kidney damage than people without the disease (Morgan et al., 2000, Center for
Disease Control & Prevention, 2011; Seshasai et al. 2014). Furthermore, it has also
been well documented that people with diabetes are at a higher risk of all-cause and
specific-cause mortality than those without diabetes (Alegre-Diaz et al., 2016; Fox,
Sullivan, D’Agostino, & Wilson, 2004; Saydah, Tao, Imperatore, & Gregg, 2009;
Seshasai et al., 2014; Shen et al., 2014; Stokes & Preston, 2017). Recent studies have
also reported that diabetes is responsible for about 11.7% of total deaths (Stokes &
Preston, 2017) and a reduction of 0.86 years of life expectancy at age 30 in the United
States in 1997-2009 (Preston, Choi, Elo and Stokes, 2018).
In studies using prospective cohorts, the relative risk of death between people
with and without diabetes has been estimated using either a biomarker for diabetes,
such as fasting plasma glucose (FPG), measured at the start of mortality follow-up (at
baseline, hereafter) or self-reported diagnosed diabetes (self-reported diabetes,
hereafter), depending on a research design or data availability. These two
measurements are often used as interchangeable alternatives in the literature without
recognizing differences between the two measurements. In this chapter, I argue that
self-reported diabetes and baseline biomarkers for diabetes at baseline are not identical
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in terms of the time of the measurement and characteristics of the disease in relation to
mortality risk.
Using a nationally representative sample, this chapter examines the risk of
death associated with diabetes by using both self-reported diabetes and baseline
HbA1c. By doing so, this chapter will contribute to the literature by suggesting an
alternative method of classifying diabetes status in studies of diabetes and mortality.
Furthermore, the simultaneous use of both self-reported diabetes and biomarkers will
answer the following important questions: how does the mortality risk vary among (1)
persons who have never been diagnosed with diabetes; (2) those who are able to
control their high blood glucose levels; (3) people with undiagnosed diabetes; and (4)
individuals with diabetes who have not been able to control their diabetes?

2.2 Literature Review
2.2.1 Biomedical Indicators for Diabetes and Mortality
Diabetes is a combination of diverse metabolic disorders resulting from chronic
hyperglycemia with dysfunction of insulin secretion and/or insulin action (American
Diabetes Association 2010). Diabetes occurs when the pancreas does not produce
enough insulin that converts sugar inside the cells into energy or insulin in the body
cannot be properly used. People with diabetes are unable to regulate a blood sugar
level which leads to high glucose concentration and development of vascular
complications. Health providers typically diagnose diabetes through assessing the
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amount of sugar in blood, for instance, based on FPG and 2-hr glucose concentration
during an oral glucose tolerance test (OGTT).
Recently, HbA1c test has been recommended for screening and diagnosing
diabetes by the American Diabetes Association (ADA) and International Expert
Committee because of its distinct advantages over the traditional diagnostic strategies,
especially measures of plasma glucose (Hussain, 2016). The term HbA1c refers to
hemoglobin that binds with glucose in blood cells. A level of HbA1c – the percentage
of glycated hemoglobin relative to total hemoglobin – indicates an average level of
plasma glucose that sticks to the blood cells over a two to three months period. The
ADA, International Expert Committee and WHO recommended the use of a HbA1c
value of ≥ 6.5% for a diagnostic criterion for diabetes and HbA1c levels between 5.7%
and 6.4% for a diagnostic criterion for prediabetes (ADA, 2010; International Expert
Committee 2009).
The most prominent advantages of HbA1c relative to other glycemic indices
are its high repeatability, reliability, little intra-person variation, day-to-day variability
of glucose levels and availability during non-fasting state (International Expert
Committee, 2009; Bonora & Tuomilehto, 2011). In particular, when compared to FPG
or 2-hr OGTT that assess blood sugar concentration at a moment of a single day,
HbA1c appears to better measure chronic-hyperglycemia for the previous 120 days and
to be less affected by various factors at the examination, such as fasting status,
providing more reliable information on blood glucose levels (Davidson, Peters,
Schriger 1995; Adams et al., 2009; Guo, Moellering, & Garvey, 2014). In addition,
studies reported that HbA1c shows better explanatory power for mortality compared to
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FPG and 2-hr OGTT (Bancks et al 2014; Selvin 2005). Due to these advantages,
HbA1c test has been strongly advocated for diagnosing diabetes and early detection
and management of diabetes (Gallagher, Le Roith, & Bloomgarden, 2009).
Using HbA1c as the main diabetic diagnostic test, a body of literature has
consistently demonstrated that increasing HbA1c is strongly associated with an
increased risk of mortality (Lazzeri et al., 2015; Saydah, Gregg, Kahn, & Ali, 2018;
Saydah et al., 2009). A study by Saydah et al. (2009) analyzed adults ages 20 and older
using NHANES III and found that adults with HbA1c levels ≥ 8% had higher risks of
mortality from all-cause (HR:2.6, 95% CI:1.9-3.6), heart disease (HR:3.4, 95% CI:2.05.8) and cancer (HR:2.4, 95% CI:1.2-6.0) compared with adults with HbA1c levels <
6%, net of potential confounding factors. In a study of 7,388 Singapore Chinese adults
conducted by Bancks et al. (2017) also found that HbA1c levels ≥ 6.5% were
significantly associated with mortality from all-cause, CVD, cerebrovascular and
cancer diseases when compared to HbA1c levels 5.4%-5.6%, net of demographic
characteristics and health behaviors (Bancks et al., 2017). The same findings were
reported from studies that adopted the HbA1c cut point ≥ 6.5% as a definition of
diabetes (Stokes and Preston 2017; Stokes and Mehta 2013).
On the other hand, several studies reported a nonlinear relationship between
HbA1c levels and excess death (Bancks et al., 2014; Carson et al., 2010; Palta, Huang,
Kalyani, Golden, & Yeh, 2017). For instance, Selvin et al. (2011) found a significant
association between HbA1c and excess death in HbA1c levels equal to or greater than
5.5%, but there was an inverse relationship below HbA1c level of 5.5%, resulting in a
J-shaped pattern. Saydah et al. (2009) also found a similar pattern; all-cause mortality
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decreases as HbA1c increases at HbA1c levels below 5%, but there was a strong
relationship between HbA1c and mortality at HbA1c levels ≥ 6% (Saydah et al., 2009).
The J-shaped, or sometimes U-shaped pattern, was also observed with FPG
(Sreenivasa et al., 2011). Although the inverse relationship between elevated HbA1c
and mortality was observed at diverse HbA1c thresholds, but these were mostly on the
left tail of HbA1c distribution, suggesting that the inverse pattern perhaps is related to
characteristics of people with very low levels of HbA1c. One possible explanation for
this phenomenon is that people with low HbA1c also have low body weight and low
cholesterol and experience malnutrition, functional decline and other comorbidities,
which are associated with higher risk of mortality (Abdelhafiz & Sinclair, 2015).

2.2.2 Self-reported Diagnosed Diabetes and Mortality
Along with HbA1c and plasma glucose indicators, many prospective cohort
studies have used self-reported data to identify diabetes status using nationally
representative survey (Alegre-Díaz et al., 2016; Gregg, Gu, Cheng, Venkat Narayan, &
Cowie, 2007; Oba, Nagata, Nakamura, Takatsuka, & Shimizu, 2008; Shen et al.,
2014). For instance, NHIS collects data on participants’ diabetes by asking the
question “Have you ever been told by a doctor or health professional that you have
diabetes or sugar diabetes?” Also, the Behavioral Risk Factor Surveillance System ask
a similar question of “Has a doctor, nurse, or other health professional ever told you
that you had any of the following?” Studies commonly assign participants who
answered “yes” to these questions as diabetic and compare them with those who
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answered “no” to assess relative risk of mortality between participants with and
without diabetes.
Although less precise compared to biomarkers, prior evidence shows high
sensitivity and specificity of self-reported diabetes. A review paper by Saydah et al.
(2003) reported that self-reported diabetes used in earlier studies showed a level of
sensitivity ranged from 70% to 99% and specificity from 92% to 99% (Saydah et al.,
2004). Schneider et al. (2012) also showed relatively high sensitivity and specificity of
self-reported diabetes; for prevalent diabetes, the sensitivity of self-reported diabetes
ranged from 58.5% to 70.8% and specificity ranged from 95.6% to 96.8% (Schneider,
Pankow, Heiss, & Selvin, 2012). The high sensitivity and specificity of self-reported
diabetes is attributable to substantial improvement in diabetes screening, clear
diagnostic criteria for diabetes and increasing attention to diabetes epidemic in recent
years (Midthjell et al 1992; Cricelli et al. 2003).
Based on self-reported diabetes, many studies have estimated relative risk of
mortality associated diabetes (Luk et al., 2016; Saydah et al., 2009; Stokes & Preston,
2017). Although these associations vary depending on the study populations, previous
studies found comparable associations between self-reported diabetes and mortality.
For instance, Gregg et al. (2018) reported a relative risk of all-cause death associated
with self-reported diabetes ranges from 1.6 to 2.0 during 1988 – 2015 with adjustment
for age, sex and race/ethnicity. One study conducted in Hong Kong by Shen et al.
(2014) showed a similar relative risk of 1.56 after adjusting for several
sociodemographic and health behavioral characteristics. Oba et al. (2009) reported a
value of 1.35 for the relative risk of having self-reported diabetes compared to not
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having diabetes in Japan after adjustment for basic demographic characteristics,
physical activity, hypertension and dietary.
Note that these values are not only comparable between studies that used selfreported diabetes, but also among studies that focused on the HbA1c criteria (Saydah
et al., 2009a; Selvin et al., 2010; Shen et al., 2014; Stokes & Preston, 2017). In other
words, the direction and magnitude of effects of diabetes on mortality observed in the
previous studies appeared to be similar when diabetes is identified based on selfreported diabetes or a baseline HbA1c level. For instance, Stokes and Preston (2017)
estimated the effect of diabetes on mortality using self-reported diabetes from NHIS
1997-2009 and a HbA1c cutoff of 6.5% from NHANES 1999-2010. Reported hazard
ratios of death associated with diabetes were very similar at 2.00 for self-reported
diabetes and 1.88 for the HbA1c criterion (Stokes & Preston, 2017).

2.2.3 The Effect of Measured and Diagnosed Diabetes on Mortality
As seen in the review of the literature, researchers have found similar
associations between diabetes and mortality when diabetes is identified by self-reports
and baseline HbA1c. Furthermore, there has been little studies that investigated
different aspects of the two indicators in estimating mortality risk associated with
diabetes. Thus, most studies tend to simply classify people into a diabetic or nondiabetic group based on either self-reported diabetes or the level of HbA1c (Brancati et
al., 1996; Saydah et al., 2009a), using the two measurements interchangeably.
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However, different characteristics of self-reported diabetes and baseline
biomarkers of diabetes have been recognized and used, especially in studies of
undiagnosed diabetes. In other words, researchers typically combine information on
individuals’ self-reported diabetes and baseline FPG or HbA1c to identify undiagnosed
diabetes (Gregg et al., 2004; Menke, Casagrande, Geiss, & CC, 2015). In their paper
on undiagnosed diabetes, for instance, Young and Mustard (2001) mentioned that
“Undiagnosed diabetes can only be detected in a survey or screening setting when
individuals are tested for plasma glucose levels and are asked about a past history of
physician-diagnosed diabetes” (Young & Mustard, 2001, p24). Following this
approach, previous studies assigned individuals as having undiagnosed diabetes when
the individuals meet the clinical criteria for diabetes, such as HbA1c ≥ 6.5% or FPG ≥
126mg/dL, but have not been previously diagnosed with diabetes (Menke, Casagrande,
Avilés-Santa, & Cowie, 2017; Selvin, Wang, Lee, Bergenstal, & Coresh, 2017).
Specifically, researchers first investigate baseline diagnostic biomarker for diabetes to
determine whether or not individuals have diabetes. Then the researchers further
classify the individuals based on self-reported diabetes to determine whether diabetes
was previously diagnosed. As such, using both measurements with a recognition of
differences between the two indicators provides more insights than when only one of
the two diabetes indicators is used. Nonetheless, this method has not been applied to
research on mortality and diabetes.
Yet, using both indicators is required to obtain a deep understanding of diabetes
and mortality patterns given how diabetes is associated with mortality. People with
diabetes often have associated complications and die from these complications
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(McEwen et al., 2016). These complications and the deleterious effects of diabetes
could be present with dysglycemia, even before a clinical diagnosis of diabetes is made
and the harmful effect of the condition can last for many years without any symptoms.
Therefore, it is important to consider accumulated damage caused by diabetes and the
development and progression of long-term complications in order to better assess the
association between diabetes and mortality.
In this regard, using either self-reported diabetes or baseline HbA1c in a
mortality study may provide insufficient understanding of the association between
diabetes and mortality. Self-reported diabetes reflects patients’ hyperglycemic status in
the past, the potential existence of complications and an accumulated negative health
impact since the onset of diabetes. However, a previous diagnosis of diabetes does not
guarantee the presence of diabetes and complications at the time of the survey,
especially if the diagnosis was made in many years ago. In addition, self-reported
diabetes could be affected by various factors, including a clinical definition of diabetes
and a diagnostic test performed at the time of the diagnosis, access to healthcare
services, a recall bias and so on. On the other hand, although baseline HbA1c may not
capture the accumulated effect of diabetes and its complications that could have been
present for many years before the survey. This is because baseline HbA1c can be
affected by the recent use of diabetes medications (although these can be identified),
lifestyle changes and patients’ diverse medical conditions at the time of blood testing
(Nitin, 2010). Thus, it is more informative to use both measures at the same time,
which allows to reflect accumulated damage from diabetes and also the current status
of diabetes that would be associated with future mortality consequences.
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In using both measurements, the time since the diagnosis of diabetes, or
duration of diabetes plays a role. As discussed previously, the main difference between
the two measurements is the time of the events. If a previous diagnosis of diabetes
occurred right before the survey date in which a blood test is performed, the two
indicators are basically identical, providing the same information. In addition, many
studies reported that the duration of diabetes is positively associated with an increased
risk of mortality (Banerjee et al., 2012; Brun et al., 2000; Creighton, Goldman, Pebley,
& Chung, 2012). Therefore, I examined the role of the duration of diabetes on
mortality to better explain how self-reported diabetes is associated with mortality, net
of baseline biomarkers for diabetes.

2.3 Aims of Chapter 2
The main aim of this chapter is to estimate the mortality risk associated with
diabetes by using both self-reported diabetes and an HbA1c threshold of 6.5% at
baseline. In addition, I investigate the association between time since the diagnosis of
diabetes and mortality based on self-reported diabetes.

2.4 Data and Methods
2.4.1 Data and Sample
Data were obtained from the third National Health and Nutrition Examination
Survey (NHANES) 1988-1994 and NHANES Continuous surveys 1999-2014.
NHANES is a series of nationally representative surveys that include noninstitutionalized US population using a multistage stratified probability sampling
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conducted by the National Center for Health Statistics (NCHS). NHANES participants
were interviewed using a standardized survey questionnaire in their home and
randomly selected participants aged 12 years or older subsequently received a physical
and laboratory examination in a mobile examination center (MEC) where extensive
medical data are collected. NHANES participants who were eligible for matching were
linked to the National Death Index (NDI) based on a 14-item identification scheme.
The NHANES participants who were eligible for the linkage with NDI were followed
up mortality status from the survey date through December 31, 2015. All follow-up
times were limited to a maximum of 5 years beyond the survey to minimize potential
biases that survey participants without diagnosed diabetes at baseline become an
incident case and HbA1c at follow-up can change during the follow-up period.
I restrict the sample to individuals aged 30 - 84 at the time of the survey and
who underwent both survey interview and medical examination from the NHANES
MEC. Respondents aged 85 or older were excluded from analysis to reduce bias
induced by mortality selection and an open-ended coding of 85+ in the continuous
NHANES. In addition, survey sample with missing information on all covariates
(n=6,011) or who died in the same month in which they were interviewed (n=7) are
excluded. The resulting sample included 40,163 observations, and there were 2,633
participants assumed to be deceased from all causes during 5-year follow-up.

2.4.2 Variable Definitions
The outcome is all-cause mortality identified in the Linked Mortality Files.
Diabetes status is assessed by a combination of self-reported diabetes and a HbA1c
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threshold of 6.5%. Self-reported diabetes is previously diagnosed diabetes constructed
based on the question asking whether the respondent had ever been told by a doctor
(NHANES III) or health professional (both NHANES III and continuous NHANES)
that they have diabetes or sugar diabetes other than during pregnancy. If answered
“yes” to the question, I assign them as diabetic. Those who answered “borderline” or
“no” are considered as non-diabetic.
HbA1c is used for a biomarker of diabetes following the American Diabetes
Association. In the NHANES, hemoglobin fractions, including A1c, from specimens
were collected and stored at the MEC and then analyzed at the University of MissouriColumbia (NHANES III and NHANES 1999-2000, 2001-2002, and 2003-2004) and
the University of Minnesota Medical Center (NHANES 2005-2006, 2007-2008, 20092010, 2011-2012, 2013-2014). There were changes in the laboratory instrument that
processes HbA1c across NHANES surveys: HbA1c was performed on the Primus
CLC330 in 1999-2004, the Tosoh A1c 2.2 Plus in 2005-2006 and the Tosoh A1c G7 in
2007-2014. The assessment of internal and external laboratory quality controls was
conducted to assess the effect of the changes in instruments on the distribution HbA1c
using cross-over studies. There was no evidence that changes in laboratory method,
survey design or population distribution affects the distribution of HbA1c across
surveys (See online supplement1). Thus, I used HbA1c values without calibrating it,
following the recommendation from the CDC. Based on most recent treatment

1

https://wwwn.cdc.gov/Nchs/Nhanes/2011-2012/GHB_G.htm
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guidelines suggested by the American Diabetes Association, participants with a HbA1c
a HbA1c threshold of 6.5% is used to identify diabetes (ADA, 2009).
Based on self-reported diabetes and the HbA1c cut point of 6.5%, the sample
adults are categorized into four groups: (1) no diabetes for participants with HbA1c <
6.5% and without self-reported diabetes; (2) controlled diabetes for participants with
HbA1c < 6.5% and with self-reported diabetes; (3) undiagnosed diabetes for
participants with HbA1c ≥ 6.5% and without self-reported diabetes; and (4)
uncontrolled diabetes for participants with HbA1c ≥ 6.5% and with self-reported
diabetes.
Previous studies often treat participants as diabetic if the participants are using
medications or insulin even though they do not meet the biomedical criteria of
diabetes, because only those who were diagnosed with diabetes are assumed to take
these medications (Stokes & Mehta, 2013; Stokes & Preston, 2017). Individuals with
HbA1c levels below and above 6.5% could be taking medications if they had been
previously diagnosed with diabetes. In this study, I do not consider taking diabetes
medications in categorizing diabetes status in this chapter. In addition, the current
chapter does not distinguish between type 1 and 2 diabetes because NAHNES does not
collect information on types of diabetes. However, type 2 diabetes accounts for more
than 90% of all diabetes cases (National Diabetes Statistics 2017) and, therefore,
results from this chapter are more likely to be associated with type 2 diabetes.
The covariates are grouped into three categories: sociodemographic
characteristics, health behaviors, diabetes complications. Sociodemographic
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characteristics include age at baseline, sex, race/ethnicity, and education. Age at
baseline is treated as continuously. I categorize educational attainment as less than 9th
grade, 9th – 11th grade, high school graduate, some college and 4 years of college
degree or higher. Race/ethnicity is categorized as non-Hispanic whites, non-Hispanic
blacks, Hispanics and other racial/ethnic groups based on self-identification. Health
behaviors include smoking behavior and drinking use, BMI and having access to
healthcare services. For drinking status, I categorize it as never drinker, former drinker
and current drinker. Former drinkers are those who did not drink during the past year,
but had more than 100 drinks in lifetime. Current drinkers are people who had more
than one drink in the past year. Smoking behavior is categorized as never smoker,
former smoker and current smoker. BMI is measured at baseline and used as a
continues variable. Having access to health care is a binary variable constructed based
on a survey question asking whether participants have a place (or more than one place)
that they usually go when they are sick or need advice about their health. Diabetes
related complications of interest are hypertension, hear failure, heart attack, stroke,
kidney problems and activity limitations. All variables are binary and constructed
based on self-reports by survey participants. Different survey questions for activity
limitations are used for NHANES 3 and continuous NHANES 1999-2014. NHANES 3
survey asked a question of “Have you ever changed your job, stopped working, or
made any changes in your housework because of a disability or health problem?” On
the other hand, continuous NHANES asked “Does a physical, mental or emotional
problem now keep you from working at a job or business?” Although the questions are
not identical, I code both as to having limitations versus no limitations.
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The duration of diabetes is constructed based on self-reported age at the survey
date and a NHANES survey question asking, “How old were you when a doctor or
other health professional FIRST told you that you had diabetes or sugar diabetes?” The
duration is then calculated as the participant’s age at the survey minus the age at the
diagnosis. In regression models that examine the effect of duration of diabetes on
mortality, participants who were diagnosed with diabetes 30 years prior to the survey
year or longer were excluded (n=576 or 1.4% of the total sample) to obtain more
reliable results.

2.4.3 Statistical Approach
In descriptive analysis, I calculate age-standardized death rates and prevalence
of the six complications as well as weighted prevalence of other covariates by the four
diabetes status groups defined above. A series of Royston-Parmar survival models are
estimated to assess relative hazard of death from all causes and its 95% CI between the
diabetes groups. While Cox Proportional Hazard model has been commonly used in
prior mortality studies, this model assumes a proportionality of hazard. The RoystonParmar survival is flexible parametric survival model that flexibly fits the baseline
hazard function on the proportional hazard scale at any time point in analysis. This
feature allows to estimate an absolute impact of risk factors at all time points (Royston
and Lambert, 2011) which is needed to calculate survivorships for the four diabetes
groups during the follow-up. In a preliminary analysis, it is observed that hazard ratios
estimated by Cox Proportional hazard and Royston-Parmar survival models are almost
the same.
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I specify three models: Model 1 adjusts for the four diabetes status groups, age
at baseline, sex, race/ethnicity and education. Model 2 additionally controls for health
behaviors that include smoking and drinking, BMI and not having access to healthcare.
Model 3 further adds the six self-reported complications. In all models, no diabetes is
the reference category. After fitting each of the three models, adjusted Wald tests are
conducted to examine mortality differentials between the four diabetes groups.
The effect of diabetes duration is estimated in Models 4 and 5. In these models,
participants with self-reported diabetes, thus either with controlled diabetes or
uncontrolled diabetes, are categorized into three groups by the duration of diabetes:
less than 10 years, 10-19 years and 20-30 years. These groups are compared to
participants without self-reported diabetes (either no diabetes or undiagnosed diabetes).
Model 4 adjusts for the diabetes and duration status defined above and covariates used
in Model 2. In Model 5, baseline HbA1c is additionally included.
In all models, follow-up times are limited to a maximum of 5 years beyond the
survey date to reduce a bias that could come from participants being diagnosed with
diabetes or experienced changes in their HbA1c during the follow-up. All analyses
account for the NHANES complex survey design and stratified multistage cluster
sample using STATA 15 (StataCorp LP, College Station, Tx).

2.4.4 Sensitivity Analysis
Several sensitivity analyses are performed to assess the validity of results. In
one sensitivity analysis, I use two additional cut points of HbA1c level of (1) ≥ 5.7%
and (2) ≥ 7.0% in categorizing diabetes status to examine potential variation in results
51

due to different HbA1c thresholds. These specific cut points are selected to align with
the guidelines of prediabetes (HbA1c levels between 5.7% and 6.4%) and sever
hyperglycemia (HbA1c ≥7.0%) made by the American Diabetes Association (ADA
2007). In a second sensitivity analysis, FPG is also used in combination with HbA1c;
people with HbA1c ≥ 6.5% or FPG ≥ 126 mg/dl (or ≥ 7.0 mmol/L) or higher are
considered as diabetic. Because information on plasma glucose were collected from
participants who attended a MEC morning fasting session only, this sensitivity analysis
is conducted among the restricted sample of 25,503.

2.5 Results
2.5.1 Descriptive Analysis
Table 2-1 presents the characteristics of the sample by HbA1c ≥ 6.5% and selfreported diabetes. Participants with no diabetes accounted for the majority of the
sample (88.2%) and the proportion of participants with controlled diabetes (3.4%),
undiagnosed diabetes (2.3%) and uncontrolled diabetes (6.0%) were relatively small.
Higher age-standardized all-cause death rates (per 1,000 person-years) were
distinguished by self-reported diabetes, rather than by the HbA1c criterion; death rates
were 16.1 among those with controlled diabetes and 18.1 among those with
uncontrolled diabetes, whereas much lower rates were observed for participants with
no diabetes at 8.2 and undiagnosed diabetes at 10.1. The mean HbA1c was higher
among individuals with undiagnosed diabetes (7.6%) and uncontrolled diabetes
(8.2%) relative to individuals with no diabetes (5.4%) and controlled diabetes (5.9%).
Participants with no diabetes were more likely to be a never smoker, current drinker
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and have lower BMI than those in the other diabetes groups. The two groups with selfreported diabetes (either controlled diabetes or uncontrolled diabetes) were much more
likely to have access to healthcare than the other two groups without self-reported
diabetes (either no diabetes or undiagnosed diabetes). Similar to the distribution of
death rates, prevalence of six complications appeared to be higher among adults with
self-reported diabetes than those without it and relatively small differences in the
prevalence of complications were observed within the HbA1c criterion. For instance,
self-reported hypertension was present in 60.9% among participants with controlled
diabetes and 57.9% among those with uncontrolled diabetes, but percentages were
lower at 31.8% and 46.9% among individuals with no diabetes and undiagnosed
diabetes, respectively.

2.5.2 Results from Royston-Parmar Regression Models
Table 2-2 shows results from three Royston-Parmar survival regression models,
expressed as hazard ratios with 95% confidence intervals. Model 1 shows that two
groups with self-reported diabetes, individuals with controlled diabetes (HR:1.54, 95%
CI: 1.33-1.78) and uncontrolled diabetes (HR:1.73, 95% CI: 1.56-1.93), had a
significantly higher risk of death than the reference group, participants with no
diabetes. However, there was a no significant difference between the reference group
and those with undiagnosed diabetes (HR:1.01, 95% CI: 0.83-1.22). Age and being
male were significantly associated with excess death. As expected, Blacks had a
significantly higher hazard of death than Whites, whereas Hispanics and other racial
groups had a significantly lower hazard.
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In Model 2 in which smoking behavior, drinking status, baseline BMI and
healthcare access are further included, there was little to no differences in the hazard
ratios of the diabetes status compared to Model 1. The two groups with self-reported
diabetes still had 61-85% higher hazard of death than individuals with no diabetes. In
addition, the non-significant difference between individuals with no diabetes and those
with undiagnosed diabetes observed in Model 1 remained. Being current and former
smoker were significantly associated with excess death. Higher baseline BMI is
associated with lower risk of death. This counterintuitive association between baseline
BMI and mortality is consistent with prior studies that have shown a similar pattern, in
contrast to when lifetime highest BMI is used (Carnethon, Rasmussen-Torvik, and
Palaniappan, 2014; Stokes and Preston, 2017).
Adjusting for the six self-reported complications in Model 3 reduced hazard
ratios by 47.5% for controlled diabetes and 29.4% for uncontrolled diabetes. Despite
the narrowing hazard of death, the two groups with self-reported diabetes (either
controlled diabetes or uncontrolled diabetes) still had significantly higher mortality
than respondents with no diabetes. Again, there was no significant difference between
participants with no diabetes and those with undiagnosed diabetes in terms of
mortality. Among the six complications, hypertension, heart attack, stroke and activity
limitations were significantly associated with all-cause mortality. Hazard ratios of
heart attack (HR:1.08, 95% CI:0.95-1.21) and kidney problems (HR:1.04, 95% CI:
0.93-1.16) are higher than 1.00, but they are not statistically significant.
Adjusted Wald tests are performed after fitting each of the models in order to
compare hazard of death between the four diabetes groups (results are not shown). All
54

tests showed the same pattern. First, there was no significant difference between
individuals with controlled diabetes and uncontrolled diabetes. Second, hazard of
undiagnosed diabetes was significantly different from controlled diabetes and
uncontrolled diabetes, indicating that respondents with undiagnosed diabetes had a
significantly lower mortality risk than individuals with self-reported diabetes. These
results suggest that adjusted hazard of death for adults with self-reported diabetes was
significantly greater than that of adults without self-reported diabetes, regardless of
their diabetes status based on baseline HbA1c.
This observation is well described in Figure 2-1 that presents predicted
survivorship by the four diabetes statuses during the 5-year follow-up. With advancing
follow-up time, differences in survivorship between groups with and without selfreported diabetes were increasing, whereas relatively small differences were found by
the HbA1c criterion. In addition, individuals without self-reported diabetes (either no
diabetes or undiagnosed diabetes) showed relatively higher survivorship over the
follow-up period compared to those with self-reported diabetes (either controlled
diabetes or uncontrolled diabetes). The two groups with self-reported diabetes
experienced a sharp decrease in their survivorship and their probability of survival was
lower than 0.9 at the end of the follow-up.
A more conventional approach of testing the effect of diabetes on death is to
use either HbA1c ≥ 6.5% or self-reported diagnosed diabetes. When these two
indicators are estimated in separate models net of all covariates used in Model 3 (Table
A1 in Appendix), both HbA1c ≥ 6.5% (HR:1.38, 95% CI:1.25-1.52) and self-reported
diabetes (HR:1.49, 95% CI:1.36-1.64) were significantly associated with increased
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hazard of death which is consistent with most previous findings (Stokes and Preston,
2017).
Table 2-3 presents the association between diabetes duration and mortality. The
mean duration of diabetes at baseline among adults with self-reported diabetes was
11.5 years (sd:0.83). Model 4 adjusts for all covariates used in Model 2. This model
shows the significant effect of the duration of diabetes, such that, longer duration was
associated with an increased risk of death. In Model 5 that further includes baseline
HbA1c level, the significant effect of duration remains, although hazard ratios of
duration were slightly reduced. In addition, there was a significant association between
continuous HbA1c at baseline and mortality; each 1% increase in baseline HbA1c level
increased hazard of death by a factor of 1.08 (Model 5, Table 2-3).

2.5.3 Results from the Sensitivity Analysis
Table 2-4 shows results from three sensitivity analyses. First, using HbA1c cut
points of 5.7% (presented in Model 6) and 7.0% (presented in Model 7) did not
significantly change results found in the previous models in which HbA1c ≥ 6.5% is
applied, except for undiagnosed diabetes. One difference is that individuals with
undiagnosed diabetes in Model 6 (HR:1.10, 95% CI: 1.01-1.21) and Model 8
(HR:1.19, 95% CI: 1.01-1.40) had a significantly higher risk of death than those with
no diabetes. This change found in Model 6 results from recategorizing participants
whose HbA1c is between 5.7% and 6.4% from no diabetes into undiagnosed diabetes.
People with an HbA1c level between 5.7% and 6.4% are considered as having
prediabetes and people with prediabetes have been found to have an increased risk of
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death compared to those with normoglycaemia in prior studies (Huang et al., 2016).
Therefore, recategorizing these participants from no diabetes to undiagnosed diabetes
results in increased relative risk of death for respondents with undiagnosed diabetes
compared to respondents with no diabetes. A similar pattern is observed in Model 8.
Participants with HbA1c <6.5%, but with ≥126 mg/dL are assigned as undiagnosed
diabetes in Model 8, who are considered as no diabetes when the HbA1c criterion only
is used. Because people with FPG ≥ 126 mg/dL are commonly considered as diabetic
and these people are at an increased mortality risk, assigning them in undiagnosed
diabetes in Model 8 results in the higher risk of mortality for this group compared with
no diabetes. With regard to controlled diabetes and uncontrolled diabetes, there were
no changes from the main results in these sensitivity analyses: these two groups still
had a higher risk of mortality than the no diabetes group. Thus, the results from these
sensitivity analyses indicate that the mortality risk of the undiagnosed group is
sensitive to the way in which this group is defined.

2.6 Discussion
This chapter examines the mortality risk associated with diabetes by
considering both baseline HbA1c and self-reported diabetes. When the two
measurements were examined separately in a survival model, each indicator was
significantly associated with an increased risk of death. However, the simultaneous use
of these two measurements shows that the predictive role of self-reported diabetes on
the risk of death is greater than that of baseline HbA1c (Table 2-2). Furthermore,
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results show that adults with self-reported diabetes were at a higher risk of death than
adults without self-reported diabetes, regardless of their diabetes status identified by
HbA1c measured at baseline.
Then why does self-reported diabetes show a stronger association with
mortality than baseline HbA1c criteria? Explaining mechanisms for this finding is
difficult from the cross-sectional data used in this study. However, the results from this
chapter and previous studies suggest three possible explanations. First, Table 2-1
exhibits that the mean HbA1c level was significantly higher in respondents with selfreported diabetes than others without it within the same HbA1c categories, indicating
that adults who were previously diagnosed with diabetes could have a more severe
case. Likewise, the same table shows that the prevalence of six complications were
more common among adults with self-reported diabetes than those without it within
the HbA1c categories. Furthermore, it is observed that controlling for the six
complications in Model 3 (Table 2-2) considerably reduces mortality gaps between
adults with and without self-reported diabetes. These observations suggest that adults
who were diagnosed with diabetes may have more deleterious health consequences of
hyperglycemia for a longer period of time than those without self-reported diabetes.
Therefore, there might be a selection of people with more conditions to the selfreported diabetes category. These processes cannot be captured by baseline HbA1c
measure alone.
A second explanation is related to the duration of diabetes. The significant
association between longer duration and increased mortality risk has been reported in
earlier studies (Brun et al., 2000; Donaghue et al., 2003; Fox et al., 2004a; Valensi,
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Pariès, & Attali, 2003) and is also observed in this chapter (Table 2-3). Adults with
self-reported diabetes in the sample are also likely to have had diabetes longer than
adults without self-reported diabetes. The estimated mean duration of diabetes among
participants with self-reported diabetes was 11.5 years and it is less likely that adults
with hyperglycemia have had the condition longer than 10 years without being
diagnosed in the United States where the overall prevalence of undiagnosed diabetes
has been found to be very low at approximately 0.8% - 1.4% (Selvin et al., 2017).
Thirdly, the reverse relationship between HbA1c and mortality risk at lower
levels of HbA1c could also contribute to the weak impact of HbA1c. As discussed
previously, there is growing evidence showing that a J- or U-shaped pattern in the
association between HbA1c and all-cause and CVD mortality (Abdelhafiz & Sinclair,
2015; Palta, Huang, Kalyani, Golden, & Yeh, 2017). Therefore, ignoring an increased
risk of death in the very low levels of HbA1c may underestimate the effect of having
HBA1c level greater than 6.5%.
This chapter also demonstrated that respondents with undiagnosed diabetes had
a significantly lower hazard of death than respondents with controlled diabetes and
uncontrolled diabetes. The lower hazard for individuals with undiagnosed diabetes
compared with controlled diabetes group is especially interesting, given that the
undiagnosed diabetes group is identified as diabetic at the beginning of the mortality
follow-up by HbA1c, whereas the controlled diabetes group is considered as
normoglycemic based on the same test. This finding is also somewhat contrary to the
general understanding on undiagnosed diabetes; persons who are unaware of their
diabetes tend to have serious health consequences because of delayed interventions
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(Gregg et al., 2004; Menke et al., 2017). In addition, hyperglycemia has been found to
be associated with an increased risk of comorbidities, including increased oxidative
stress, vascular damages and cancer, among people without diabetes (Ceriello, 2008;
Joshu et al., 2012; Su et al., 2008). However, the current findings suggest that being
diagnosed diabetes through blood test does not necessarily result in a higher risk of
death. This result is robust to the way undiagnosed diabetes is defined (Table 2-4).
On the other hand, the risk of death for those with undiagnosed diabetes
relative to those with no diabetes is sensitive to the way undiagnosed diabetes is
defined. The results from the sensitivity analyses showed a significantly higher risk of
death for undiagnosed diabetes relative to no diabetes with an additional consideration
of those with HbA1c levels between 5.7% and 6.5% and FPG ≥ 126 mg/dL in the
definition of diabetes. Yet, regardless of how undiagnosed diabetes was defined,
participants with undiagnosed diabetes still had a lower risk of death than controlled
diabetes and uncontrolled diabetes groups in all sensitivity analyses.
The results from this chapter provide several important insights. First, the
strong impact of baseline glycemic levels, HbA1c ≥ 6.5% or perhaps other biomedical
indicators of diabetes on excess death reported in the previous literature could be a
reflective of mortality differentials between people with and without a previous
diagnosis of diabetes. Second, although several clinical randomized trials have
reported the effectiveness of intensive medical therapy to control high blood sugar
levels (Cheng et al., 2018; Zhang et al., 2017), it is unclear to what extent mortality
risks at the population level can be reduced with such treatment. The current study
shows that individuals who have been diagnosed with diabetes, regardless of whether
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their disease is controlled, have an increased risk of death relative to those who have
not been diagnosed with diabetes. Therefore, a public health intervention should focus
on primary prevention that aims to reduce risk factors for the development of diabetes
as well as target people with prediabetes.
Several limitations of this study should be acknowledged. First and most
importantly, the current chapter cannot explain how a previous diagnosis of diabetes is
linked to baseline glycemic status and a subsequent mortality risk. The previous
diagnosis of diabetes is expected to affect baseline HbA1c levels as people who were
diagnosed with diabetes tend to control their blood glucose levels through various
interventions which affects baseline HbA1c as well as mortality risk. However, since
this study uses cross-sectional data, the mechanisms underlying the associations
between self-reported diabetes, baseline HbA1c and mortality cannot be examined.
Second, all diabetes related complications used in this chapter are self-reported which
perhaps leads to an underestimation of the effect of these complications due to a
measurement error.
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TABLES
Table 2-1. Sample Characteristics by HbA1c Cutoff of 6.5% and Self-Reported
Diagnosed Diabetes. Adults Ages 30 – 84 at Baseline (n=40,103).
HbA1c at baseline
Self-reported diabetes

HbA1c < 6.5%
Undiagnosed
Diagnosed
Controlled
No diabetes
diabetes
33,780(88.2)
1,633(3.4)
151998.3
6893.7
1,850
209
8.2
16.1
5.4(0.01)
5.9(0.02)
9.6(0.4)

HbA1c ≥ 6.5%
Undiagnosed
Diagnosed
Undiagnosed
Uncontrolled
diabetes
diabetes
1,437(2.3)
3,253(6.0)
6393.8
13685.8
116
447
10.1
18.1
7.6(0.05)
8.2(0.04)
12.6(0.3)

Unweighted N (%)a
Person-years
Number of deaths
Death ratesb
HbA1c level, mean (se)
Duration of diabetesc
Race/ethnicity
Non-Hispanic White
75.3
67.5
56.8
62.5
Non-Hispanic Black
9.2
13.5
17.3
16.1
Hispanic
10.3
12.3
16.8
14.6
Others
5.2
6.7
9.2
6.8
Male
47.9
45.8
55.5
51.8
Age at baseline (se)
50.5(0.1)
60.2(0.4)
58.0(0.5)
59.7(0.3)
Educational attainment
Less than high school
17.3
25.6
30.5
30.4
High school
24.8
26.2
26.4
25.4
< 4 years college
28.2
28.8
28.5
29.0
4 years college +
29.8
19.4
14.6
15.1
Smoking behavior
Never
50.6
46.4
46.6
49.2
Current smoker
22.0
15.7
19.0
17.1
Former
27.4
37.9
34.4
33.7
Drinking status
Never
10.6
16.5
17.4
17.3
Former drinker
15.4
24.1
20.9
20.7
Current drinker
74.0
59.4
61.8
62.0
BMI (se) in kg/m2
28.2
32.2
33.7
32.8
Not having health care
12.8
2.0
13.3
3.6
Complications (se)b
Hypertension
31.8 (0.4)
60.9 (2.1)
46.9 (2.2)
57.9 (1.5)
Heart failure
2.0 (0.1)
6.1 (0.6)
3.8 (0.6)
7.2 (0.6)
Heart attack
3.3 (0.1)
6.9 (0.7)
5.0 (0.6)
9.2 (0.8)
Stroke
2.4 (0.1)
7.2 (0.9)
2.9 (0.5)
5.5 (0.4)
Kidney problems
5.8 (0.2)
8.2 (0.9)
5.8 (0.8)
9.4 (0.9)
Limitations
10.5 (0.4)
25.8 (1.8)
15.7 (1.6)
20.8 (1.1)
NHANES survey weight is accounted for. aPercentage in parentheses is weighted.
b
Age-standardized death rates using 2010 US population as the standard
No diabetes: baseline HbA1c < 6.5% and without self-reported diagnosed diabetes
Controlled diabetes: baseline HbA1c < 6.5% and with self-reported diagnosed diabetes
Undiagnosed diabetes: baseline HbA1c ≥ 6.5% and without self-reported diagnosed diabetes
Uncontrolled diabetes: baseline HbA1c ≥ 6.5% and with self-reported diagnosed diabetes
c
Only among participants with self-reported diabetes
Data source: NHANES III (1988-1994), Continuous NHANES 1999-2014 and LMF through December 31,
2015.
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Table 2-2. Estimated Hazard Ratios from Royston-Parmar Survival Models. Adults Ages 30 – 84 at Baseline.
Model 1
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Diabetes status
No diabetes (Ref)
Controlled diabetes
Undiagnosed diabetes
Uncontrolled diabetes
Male
Age at baseline, in years
Race/ethnicity
Non-Hispanic White (Ref)
Non-Hispanic Black
Hispanic
Others
Educational attainment
Less than high school (Ref)
High school
< 4 years college
4 years college +
Smoking behavior
Never smoker (Ref)
Current smoker
Former smoker
Drinking status
Never (Ref)
Former drinker
Current drinker
BMI at baseline
Not having usual health care
Complications
Hypertension
Heart failure
Heart attack
Stroke
Kidney problems
Activity limitations

95% CI

Model 2

95% CI

Model 3

95% CI

1.00
1.54
1.01
1.73
1.69
1.08

1.00,1.00
1.33,1.78
0.83,1.22
1.56,1.93
1.56,1.82
1.07,1.08

1.00
1.61
1.06
1.85
1.58
1.08

1.00,1.00
1.39,1.87
0.88,1.28
1.66,2.06
1.45,1.72
1.07,1.08

1.00
1.32
1.03
1.60
1.07
1.57

1.00,1.00
1.14,1.53
0.85,1.24
1.43,1.78
1.07,1.08
1.44,1.71

1.00
1.11
0.76
0.68

1.00,1.00
1.00,1.23
0.68,0.85
0.54,0.87

1.00
1.09
0.79
0.65

1.00,1.00
0.98,1.21
0.71,0.88
0.51,0.83

1.00
1.08
0.81
0.65

1.00,1.00
0.98,1.20
0.72,0.91
0.51,0.83

1.00
0.82
0.73
0.52

1.00,1.00
0.74,0.91
0.65,0.82
0.46,0.60

1.00
0.85
0.77
0.58

1.00,1.00
0.77,0.94
0.69,0.86
0.51,0.67

1.00
0.91
0.84
0.69

1.00,1.00
0.82,1.00
0.75,0.94
0.60,0.79

1.00
2.05
1.32

1.00,1.00
1.83,2.30
1.20,1.45

1.00
1.85
1.26

1.00,1.00
1.65,2.08
1.14,1.38

1.00
0.94
0.80
0.98
1.09

1.00,1.00
0.83,1.06
0.71,0.90
0.97,0.99
0.93,1.27

1.00
0.95
0.84
0.97
0.97

1.00,1.00
0.84,1.07
0.74,0.94
0.96,0.98
0.83,1.13

1.17
1.94
1.08
1.35
1.04
1.87

1.07,1.27
1.72,2.19
0.95,1.21
1.19,1.52
0.93,1.16
1.72,2.05

NHANES survey weight is accounted for. Ref: Reference group.
All models control for survey periods.
Bold values are significant at the 95% confidence level.

Table 2-3. The Effect of Duration of Diabetes and Baseline HbA1c on All-cause
Mortality (n=39,718).
Model 4
Model 5
HR 95% CI
HR 95% CI
Baseline HbA1c level
Diabetes status and durationa
No diabetes or Undiagnosed diabetesb
Less than 10 years
10-19 years
20-30 years

1.00
1.52
1.75
2.46

a

-

1.08

1.04,1.12

1.00,1.00
1.34,1.74
1.51,2.04
2.06,2.93

1.00
1.35
1.51
2.12

1.00,1.00
1.17,1.56
1.27,1.79
1.76,2.57

Participants whose duration of diabetes is longer than 30 years are excluded.
The reference group is participants without self-reported diabetes.
All models include age at baseline, sex, race/ethnicity, education, smoking, drinking, BMI at baseline and
access to healthcare.
Bold values are significant at the 95% confidence level.
NHANES survey weight is accounted for.
b
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Table 2-4. Sensitivity Analysis: Using Different Criteria for Diagnosing Diabetes. Adults Ages 30 – 84 at Baseline.
Model 6a
Diabetes status
No diabetes (Ref)
Controlled diabetes
Undiagnosed diabetes
Uncontrolled diabetes

Model 7b
HR
1.00
1.60
1.10
1.56

95% CI
1.00,1.00
1.23,2.06
1.01,1.21
1.40,1.74

Diabetes status
No diabetes (Ref)
Controlled diabetes
Undiagnosed diabetes
Uncontrolled diabetes

Model 8c
HR
1.00
1.33
1.20
1.69

95% CI
1.00,1.00
1.18,1.51
0.92,1.57
1.50,1.91

Diabetes status
No diabetes (Ref)
Controlled diabetes
Undiagnosed diabetes
Uncontrolled diabetes
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Ref: Reference group
All models include all covariates adjusted for in Model 3 in Table 2-2.
a
Participants with HbA1c ≥ 5.7% at baseline are assigned as diabetic.
b
Participants with HbA1c ≥ 7.0% at baseline are assigned as diabetic.
c
Participants with HbA1c ≥ 5.7% or FGP ≥126mg/dL at baseline are assigned as diabetic.
For all models, those who are assigned as non-diabetic at baseline and with self-reported diabetes are labeled as controlled diabetes.
For all models, those who are assigned as diabetic at baseline and without self-reported diabetes are labeled as undiagnosed diabetes.
For all models, those who are assigned as diabetic at baseline and with self-reported diabetes are labeled as uncontrolled diabetes.
c
An analysis is limited to a total of 25,359 adults who participated in a NHANES morning examination session.
Bold values are significant at the 95% confidence level.
NHANES survey weight is accounted for.

HR
1.00
1.84
1.19
1.71

95% CI
1.00,1.00
1.27,2.65
1.01,1.40
1.51,1.93

FIGURES
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Figure 2-1 Predicted Survival Curves during the Follow-up since the Survey Date by Self-reported Diabetes and HbA1c ≥ 6.5%.
All estimates were calculated based on Model 3 in Table 2-2.

CHAPTER 3

THE IMMIGRANTS HEALTH ADVANTAGE
IN DIABETES IN THE UNITED STATES
Abstract
Background: Foreign-born immigrants have consistently been shown to have better
health than the US-born. However, prior findings on diabetes have not been consistent.
Most studies have relied solely on self-reported diabetes which could bias the prevalence
of diabetes among immigrants downward due to immigrants’ limited access to healthcare.
This chapter examines relative risks of diabetes between the foreign-born and the US
native-born population by focusing on self-reported diabetes, biomedical indicators of
diabetes and undiagnosed diabetes.
Data and Methods: Data are from the National Health and Nutrition Examination
Survey (NHANES) 3 and continuous NHANES 1999-2016. Three diabetes outcomes are
used: self-reported diabetes, HbA1c ≥ 6.5% and undiagnosed diabetes. Multivariate
logistic regression models are fitted to examine the relative risks of the three outcomes
between the foreign-born and the US-born. In addition, associations between length of
US residence and the three diabetes outcomes are examined.
Results: The foreign immigrants were more likely to have self-reported diabetes (OR:
1.28, 95% CI: 1.13-1.45) and HbA1c ≥ 6.5% (OR: 1.36, 95% CI: 1.22-1.51) compared
with the US-born, net of age and sex. However, the foreign-born had lower odds of
having self-reported diabetes (OR: 0.75, 95% CI: 0.64-0.88) and HbA1c ≥ 6.5% (OR:
0.79, 95% CI: 0.69-0.91) after adjustment for race/ethnicity. After further adjusting for
Body Mass Index (BMI), the foreign-born no longer had a significantly lower risk
compared to the US-born. In all models, the foreign-born had greater odds of
undiagnosed diabetes compared with their US-born counterparts. In addition, immigrants
with < 15 years of US residence had an advantage in self-reported diabetes (OR: 0.76,
95% CI: 0.61-0.95), but not in HbA1c ≥ 6.5% (OR: 0.91, 95% CI: 0.74-1.12) compared
with US-born individuals.
Conclusion: A racial/ethnic composition and BMI play a role in nativity disparities in
diabetes. In addition, the foreign-born advantage in self-reported diabetes among those
who have resided in the United States for less than 15 years is in part due to their higher
prevalence of undiagnosed diabetes compared to that of the US-born.
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3.1 Introduction
Over the last three decades, immigrants residing in the US have continued to
increase in size and as a proportion of the total US population. The number of the
foreign-born was approximately 19.8 million in 1990, comprising 4.9% of the US
population, but this number increased to 44 million by 2017, which accounts for nearly
16% of the nation’s population (American Community Survey, 2017). The United States
accepts more immigrants than any other country in the world and immigrants are coming
from increasingly diverse origins, transforming the country to a more ethnically and
racially diverse society. This rapidly growing size of the immigrant population implies
that the health condition of immigrant population is of vital interest to the overall
population health and public health system of the United States.
To date, a body of literature has examined different health outcomes and
behaviors of the foreign-born population in comparison with the native-born. The most
pervasive finding in the literature is that foreign-born individuals in general have more
favorable health outcomes than their native-born counterparts, even after adjusting for
major sociodemographic characteristics (Hamilton, 2015; Kennedy, Kidd, McDonald, &
Biddle, 2015). Although the better health of immigrants than native-born groups has been
found with regard to a variety of health indicators, previous findings on diabetes have
been inconsistent (Cunningham, Ruben, & Narayan, 2008).
One limitation of the literature on diabetes is that most previous studies have
solely used self-reported diagnosed diabetes (self-reported diabetes hereafter). However,
using self-reported diabetes may not provide accurate estimates of actual relative risk of
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diabetes between foreign-born and native-born individuals because of the former’s
limited access to healthcare. With barriers in accessing health care services, immigrants
are likely to have a lower chance of detecting their diabetes in the US, which could bias
downward the prevalence of self-reported diabetes among immigrants relative to nativeborn individuals.
In this chapter, I aim to examine diabetes disparity between US-born and foreignborn individuals with a special attention to self-reported diabetes as well as diabetes
status measured based on biomedical indicators. The specific aims of this chapter are
twofold. First, I examine the relative risk of diabetes among US immigrants compared
with the native-born using self-reported diabetes, a measurement of HbA1c and
undiagnosed diabetes. Using these outcomes allows me to examine whether and to what
extent underreported cases of diabetes affects a difference in diabetes risk between the
foreign-born and native-born Americans. Second, I examine the association between
length of US residence and the three diabetes outcomes to examine potential variations
among immigrants by time spent in the US.
In the next section, I summarize studies of immigrant health and hypotheses for
the favorable health outcomes of the foreign-born. I further describe these discussions in
the context of diabetes and explain how using self-reported diabetes provides inaccurate
estimates.
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3.2 Literature Review
3.2.1 The Health of Immigrants, and Diabetes
Earlier research has consistently found that foreign-born individuals have lower
mortality than native-born Americans (Abraído-Lanza et al. 1999; Sorlie et al. 1993;
Borrell and Lancet 2012; Hummer et al; 1999a). These studies in general have found
lower mortality rates among Hispanic subgroups over non-Hispanic Whites, and this
mortality advantage that Hispanics enjoy is largely attributable to high percentages of
foreign-born individuals among Hispanics (Borrell and Lancet 2012; Hummer et al;
1999a). The lower risk of mortality among immigrants has also found in other
racial/ethnic subpopulations, including Blacks and Whites (Singh and Siahpush, 2001;
Singh and Siahpush, 2002).
The health advantage of immigrants has also been observed with regard to some
other major health indicators such as birth outcomes (Hummer et al., 1999b),
overweight/obesity (Antecol and Bedard, 2006), cigarette smoking (Singh and Hiatt,
2006) and disability (Cho and Hummer, 2001), although these advantages do not extend
to all health indicators. For example, foreign-born individuals tend to report worse selfreported health, mental health, occupational injuries, stomach and brain cancers and
access to healthcare (Cunningham et al., 2008).
Diabetes is also one of these exceptions; overall, studies of diabetes have found
inconsistent or sometimes conflicting evidence. Many studies that analyzed nationally
representative US samples reported different findings depending on race/ethnicity of
study populations and confounding variables. One study that compared adjusted
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prevalence of self-reported diabetes of the foreign-born to that of the US-born aged 18 or
older found no significant difference between the two groups both in 1993 and 2003
based on National Health Interview Survey (NHIS) waves 1993 and 2003 (Singh and
Hiatt, 2006). However, based on 47,751 foreign-born and US-born blacks from NHIS
waves 2000-2013, Ford, Narayan and Mehta (2015) reported that foreign-born blacks had
a significantly lower prevalence of self-reported diabetes than their US-born counterparts,
net of sociodemographic characteristics and smoking, but the advantage of the foreignborn disappeared with an adjustment for BMI. Riosmena, Wong and Palloni (2013) who
analyzed NHIS 1997-2007 waves also show that Mexican immigrants with <15 years of
US residence were not statistically different from US-born Whites in terms of selfreported diabetes. They also found that US-born Mexican Americans had a significantly
higher odds of self-reported diabetes than US-born Whites (Riosmena, Wong and Palloni,
2013). Different from these studies, one study conducted by Oza-Frank et al. (2013)
observed that foreign-born Latinos had higher risks of incident diabetes (measured by
fasting plasma glucose) than US-born Latinos, using a sample from the Multi-Ethnic
Study of Atherosclerosis.
However, studies that focused on certain geographic areas and subpopulations
also reported contrasting findings. Foreign-born Asian Indians living in Atlanta, Georgia
(Venkatraman et al. 2004), foreign-born blacks living in New York City (HorlyckRomanovsky et al., 2019) and foreign-born South Asians in New York City (Gupta, Wu,
Young, & Perlman, 2011) have been found to have a higher prevalence of self-reported
diabetes compared to US-born non-Hispanic whites or their US-born co-ethnic
counterparts. One study of Beard et al. (2009) addressed that the prevalence of self71

reported diabetes and diabetes-related complications has increased dramatically among
Mexican Americans between 1993-1994 and 2004-2005 using data from the Hispanic
Established Population for the Epidemiologic Study of the Elderly (Beard et al., 2009).
These mixed findings may be attributable to many factors, such as different study
populations, research designs and confounding variables. Among these factors, using
self-reported diabetes for identifying diabetes might contribute to the heterogeneity.
Although self-reported diabetes shows high sensitivity and specificity in identifying
people with diabetes in a general population (Saydah et al., 2004), a misclassification
issue could be critical when this measurement is used in assessing the prevalence of
diabetes among immigrant populations. It is now well-documented that immigrants are
vulnerable to inadequate healthcare access and have poorer healthcare utilization than the
native-born due to immigrants’ lack of knowledge of US healthcare system and language
proficiency (Derose, Escarce, & Lurie, 2007; McDonald, Manlove, & Ikramullah, 2009).
For instance, previous studies have demonstrated that immigrants are less likely to
participate in cancer screening (Snider, Beauvais, Levy, Villeneuve, & Pennock, 1996;
Wong-Kim and Wang, 2006), more likely to have no health insurance coverage (Dey &
Lucas, 2006; Trevino et al., 1991; Olveen et al., 2000), face lower quality of healthcare
services (Elliott and Gillie, 1998; Feldman et al., 2009) and have fewer preventive and
non-preventive doctor visits (Xu, 2005) than US-born natives. With regard to diabetes,
prior evidence shows that diabetic immigrants are less likely to have health insurance
coverage and a usual source of care than US-born individuals with diabetes (Dallo et al.,
2009). With infrequent visits to doctor and barriers to healthcare access, it is more
difficult for immigrants to find out the onset of diabetes in the US or preexisting diabetes
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that they brought from the country of origin. This lower chance of finding out diabetes
would distort the prevalence of diabetes among immigrants in survey downward, which
exaggerates their potential advantage in diabetes over natives. Therefore, relative risk of
diabetes among immigrants compared with that among US-born Americans might be
underestimated when researchers use only self-reported data. In addition, the extent to
which estimates are underestimated may vary depending on sociodemographic
characteristics of immigrants and how well they are incorporated into the US society,
both of which are associated with the use of and access to healthcare.
In the study of immigrant health, two major explanations have been proposed as
pathways through which immigrants are in better health than their US-born counterparts:
(1) health selection and (2) cultural buffering. These two explanations are also expected
to provide a useful theoretical tool for a better understanding of nativity disparities in
diabetes. In the following section, I review literature on the two hypotheses with a special
attention to diabetes.

3.2.2 Immigrant Health Selection and Diabetes
Immigrant health selectivity operates in two ways through which immigrants
have, on average, more favorable health status than natives; in-migration and outmigration selection on health. In migration selectivity, or the “healthy migrant effect,”
hypothesizes that those who are involved in international migration are not randomly
selected people from their birth countries, instead they are likely to be healthier
physically, psychologically and financially than non-migrants in the country of origin due
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to self-selection and US screening of immigration (Crimmins et al., 2005; Jasso et al.
2004).
Similarly, out-migration selectivity, also known as the “salmon bias effect,” posits
that the negative health selection into return migration occurs because unhealthy
immigrants tend to return to their birth country, leaving only healthier immigrants in the
receiving country (Turra and Elo, 2008; Palloni and Arias, 2004). In addition, there is
mortality selection among less-healthy immigrants at older ages, thereby leaving
healthier immigrants being observed in the US (Markides and Rote, 2018). Then both
ways of selectivity leave more robust immigrants in the destination country, resulting in
overall better health status of the immigrants compared with the nave-born population
(Palloni and Morenoff, 2001). Prior studies that empirically examined the two hypotheses
found the existence of the in-migration selection effect (Mehta & Elo, 2012; Cunningham
et al., 2008), while a weak support for the out-migration selectivity (Turra and Elo,
2008).
People with diabetes often have diabetes complications and sometimes have
serious illness and disability, such as blindness, that reduces their chance to undertake a
taxing international US migration process. Thus, according to the selective migration
hypotheses, immigrants would be expected to be less likely to have diabetes than both
non-migrants in the country of origin as well as the overall population in the US (the
healthy migrant effect). In addition, by the same token, people with diabetes in the US are
expected to be more likely to return to their home country in order to have a better
treatment with supports from family members (the salmon bias). Together, these
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selection processes may give rise to a lower prevalent diabetes among immigrants
compared with the native-born.
However, the selection hypotheses perhaps operate differently with regard to
diabetes due to the unique features of diabetes. First, diabetes often has an asymptomatic
phase that could last many years (ADA, 2010), and people who are not aware of diabetes
may decide to migrate without knowing that they have the disease. In this case, the
people with diabetes ought to have the same chance of migrating as people without
diabetes. Second, even though migrants are aware of diabetes, they may still decide to
migrate to the US because diabetes can be controlled and managed with selfadministrated treatments and medications. Furthermore, people with known diabetes but
without serious complications may not view the disease as a critical barrier that prevents
them from moving to other countries for an important motivation, i.e., to find better job
opportunities and family reunification.
From the perspective of out-migration selectivity, it is also possible that people
who have the disease in the United States may want to remain in the country, instead of
returning to their birth country, if they find US healthcare system for treating diabetes to
be better than in the country of origin.
If these hypotheses are true, there would be no selection process in which people
without diabetes are more likely to migrate and, therefore, there would be little
theoretical ground to assume that US immigrants have a particularly lower risk of
diabetes than the US-born. One study finds evidence supporting this idea; this study
examined in- and out-migration selectivity in self-reported diabetes by comparing
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Mexican immigrants living in the US and Mexicans living in Mexico with and without
US migration experience. The authors found no significant difference in the risk of selfreported diabetes between the two groups, suggesting that the two selection processes on
self-reported diabetes are limited (Riosmena et al., 2013).
In addition to these theoretical considerations, high prevalence of diabetes and
undiagnosed diabetes in major US immigrant-sending countries can be another reason for
a potential weak effect of the selectivity process. Mexico and India, two largest
immigrants sending countries to the US for the last decade, showed age-standardized
diabetes prevalence in 2014 to be 10.4% and 11.0%, respectively, among adults ages 2079, while the prevalence was 10.8% in the US in the same year (World Development
Indicator, 2017). Furthermore, International Diabetes Federation reported that the
prevalence of undiagnosed diabetes among people ages 20-79 in North American and
Caribbean countries reaches 25.0% - 29.4% in 2013 (International Diabetes Federation,
2013) and these estimates were comparable to that of the US (Selvin et al., 2017).
Due to the nature of the explanations, the selection hypotheses can only be tested
by comparing health outcomes of migrants living in the US, those who returned to the
sending country and non-migrants in the same country (Riosmena et al., 2013). As such,
several studies used binational data with which health of migrants, non-migrants and
returned migrants can be compared (Bostean, 2013; Feliciano, 2005; Riosmena et al.,
2013). Unfortunately, this chapter uses the data that include US population only, making
it impossible to test for the existence and magnitude of the emigration and return
selection effects. Given the salmon bias effect, it could be that the risk of diabetes
observed in foreign-born individuals is likely to be underestimated.
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3.2.3 Cultural Buffering Effects
Another major explanation for the immigrant health advantage pertains to cultural
factors that affect favorable health behaviors, social support and family ties that have
health protective effects for immigrants (Abraído-Lanza, Chao and Flórez 2005; Scribner
1996). Researchers suggested that Hispanics’ favorable health behaviors of origin
contribute to their lower mortality rates (Abraido-Lanza et al., 2006). Subsequently, the
health protective effect of origin culture has also been observed in other racial/ethnic
immigrant groups. Prior studies have shown that foreign-born individuals are less likely
to engage in detrimental health behaviors such as smoking, drinking, and substance
abuse, and tend to have healthier diet than their US-born counterparts, which offsets
negative health effects from their lower SES (Abraído-Lanza et al. 1999; Palloni and
Arias 2004).
The effect of cultural orientation on health behaviors has been typically measured
using a concept of acculturation, which is the process in which immigrants adopt the
norms, attitudes and lifestyles of the destination country (Clark and Hofsess, 1998).
Using this concept, much evidence shows that more acculturated immigrants tend to have
more detrimental health outcomes than their less acculturated counterparts (AbraidoLanza, Chao, & Flórez, 2005), which has been referred to as a “negative acculturation
effect.” For instance, immigrants with more US experience have been found to have
higher risks of obesity (Antecol and Bedard 2006), unhealthy diet (Akresh 2007) and
smoking and alcohol use (Cho et al 2004) compared with immigrants with lower levels of
acculturation.
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The literature on acculturation and health has several implications for the current
study because some health behaviors, especially smoking and BMI, are important factors
responsible for the development and progression of diabetes. If immigrants with lower
levels of acculturation keep their protective health behaviors, i.e., healthy diet and nonsmoking behavior in the US, they are expected to have lower rates of diabetes than more
acculturated co-ethnic groups as well as the native-born.
However, studies have shown inconsistent evidence of acculturation and diabetes
patterns. For instance, one study of 520 Arab Americans conducted in Dearborn,
Michigan reported that lower acculturation was associated with higher risk of being
dysglycemica (impaired fasting glucose, impaired glucose tolerance and diabetes) when
acculturation was measured by various factors, including age at migration, consuming
origin food, language use and integration into American society (Jaber et al, 2003). The
same pattern was observed among Mexican Americans in Texas. Individuals with lower
values on three measures of acculturation (functional integration with mainstream
society, value placed on Mexican culture and attitude toward traditional family structure
and sex-role organization) were associated with an increased risk of self-reported
diabetes (Hazuda, Haffner, Stern, & Eifler, 1988). In contrast, other studies of Japanese
(Fujimoto et al., 2000), Australian aborigines (O’Dea, 1991) and non-Mexican origin
Hispanics (Kandula et al., 2008) showed a positive relationship between higher levels of
acculturation and an increased risk of self-reported diabetes. One study that used diabetes
medication, self-reported diabetes and fasting plasma glucose to identify diabetes
exhibited insignificant effect of acculturation on the risk of diabetes among adults aged
60-101 living in California’s Sacramento Valley (Afable-Munsuz et al. 2014). Using
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different acculturation measurements (Lara et al., 2005) and a range of study populations
(Cunningham et al. 2008) are likely to contribute to these mixed findings.

3.2.4 Length of Residence and Diabetes
Of many proxies for acculturation, duration of US residence is one of the most
frequently used indicators in the literature on immigrant health (see a review paper done
by Lara et al. 2005). Prior studies that used length of residence typically assumed that
longer duration of stay is correlated with higher levels of acculturation. From this
perspective, researchers posit that immigrants’ favorable health upon arrival erodes with
additional years in the country, converging to native-born levels, as they adopt unhealthy
lifestyles of the US population (Scribner 1996; Jasso et al., 2004). For instance,
immigrants with longer duration of residence are more likely to be a current smoker and
smoke more frequently than those who have spent less time in the country (AbraidoLanza et al., 2005; Gorman, Read, & Krueger, 2010; Kimbro, 2009). This negative effect
of duration has been reported with alcohol consumption (Abraido-Lanza et al., 2005;
Lopez-Gonzalez, Aravena, & Hummer, 2005), chronic conditions (Singh and Siahpush
2002), high BMI or being overweight/obese (Antecol & Bedard, 2006; Bostean, 2013b),
activity limitations (Cho, Frisbie, Hummer, & Rogers, 2004), allostatic load (Peek et al.,
2010), acculturative stress (Devylder et al., 2013) and self-reported health (Kimbro,
Gorman, & Schachter, 2012). In contrast, several studies have also found that longer
duration of US residence to be beneficial, including increased earnings, better English
proficiency, access to healthcare and knowledge on US healthcare system (Chesney et al.
1982; Kaushal and Kaestner 2013; Marks, Garcia, and Solis 1990; O’Malley et al. 1999;
Pérez-Stable, Marín, and Marín 1994; Wong, Díaz, and Higgins 2006). Because health
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behaviors and using healthcare services are directly associated with the development and
detection of diabetes, it is expected that a large share of variation between foreign-born
individuals in terms of diabetes and undiagnosed diabetes could be captured when
duration of residence is accounted for.
Given a positive association between length of residence and several health
indicators that are key risk factors for diabetes, such as BMI (Gregg et al., 2004),
smoking (Willi, Bodenmann, Ghali, Faris, & Cornuz, 2007) and psychosocial stress
(Kelly & Ismail, 2015), it is logical to assume that immigrants with longer US duration
have a higher risk of diabetes than recent arrivals. Although findings vary depending on
study designs, prior studies in general reported a positive relationship between longer
duration of US residence and the prevalence of diabetes. Riosmena, Wong and Palloni
(2013) found that Mexican immigrants with 15+ years of duration of residence in the US
had a significantly higher risk of reporting self-reported diabetes than those with <5 years
of duration. However, there were no significant differences between 5-9 years and 10-14
years, and <5 years of duration of stay. Horlyck-Romanovsky et al. (2019) reported a
significant difference in the odds of self-reported diabetes between foreign-born blacks
with less than 10 years of US residence and those with 10 years or longer stay. Another
national study using NHIS waves of 1997-2005 found an increase in adjusted prevalence
of diabetes with increased length of residence in the United States, independent of BMI
(Oza-Frank, Stephenson and Narayan, 2011). One study that measured diabetes based on
fasting glucose level and the use of diabetes medication found that immigrants living in
the US for 20 years or longer had a higher adjusted risk of incident diabetes than those
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with less than 20 years of duration of stay, but this study is limited to a small sample size
and focuses on incident diabetes only (Oza-Frank et al., 2013).
Most of these studies focused on self-reported diabetes. As discussed earlier,
using self-reported diabetes is subject to a underreporting problem, which leads to an
underestimation of the actual prevalence of diabetes among immigrants. Using a variety
of measures of diabetes, such as self-reported diabetes, biomarkers of diabetes and
undiagnosed diabetes, can help to elucidate how duration of stay may be correlated with
diabetes. First, immigrants with a longer duration of stay may have an increase in the risk
of diabetes if they adopt unfavorable US health behaviors, i.e., cigarette smoking and
unhealthy diet, over time. This process results in an increase in the prevalence of both
self-reported diabetes and diabetes identified by biomarkers. Second, as immigrants have
improved healthcare access and better health insurance with increasing duration of
residence, the immigrants can have a better chance of finding out their diabetes status,
resulting in an increase in detected cases and thus an increase in the prevalence of selfreported diabetes, regardless of changes in the actual incidence of the disease in this
population (Antecol & Bedard 2006; McDonald and Kennedy 2004). Lastly, given that a
longer duration of stay is associated with access to preventive healthcare and timely
screening of diabetes, the prevalence of diabetes may not be associated with longer
duration of US residence.
It is likely that all three pathways operate at the same time offsetting each other,
attenuating the reliability of the association between duration of stay and diabetes. One
way to avoid this problem is to further estimate the association between time in the US
and biomarkers for diabetes and undiagnosed diabetes. If the second scenario is true, the
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prevalence of diabetes identified by biomarkers would remain constant over time, while
the prevalence of self-reported diabetes among the foreign-born would increase with the
decrease in undiagnosed diabetes.

3.3 Aims of Chapter 3
The aims of this chapter are twofold. The first aim is to examine the relative
diabetes risk of US immigrants compared with native-born Americans by focusing on
self-reported diabetes, a biomarker for diabetes and undiagnosed diabetes. The second
goal is to assess the association between the three diabetes outcomes among immigrants
by the duration of US residence.

3.4 Data and Methods
3.4.1 Data and Sample
Data are from the National Health and Nutrition Examination Survey (NHANES)
3 (1988-1994) and 1999-2016 waves of continuous NHANES. The NHANES is a series
of cross-sectional household surveys that collect information from a nationally
representative sample of the non-institutionalized civilians in the United States. All
analyses in this chapter were based on public-use data. The sample of this study was
restricted to self-identified native-born and foreign-born non-Hispanic whites, nonHispanic blacks and Hispanics aged 30-80. Of all NHANES participants who meet the
above criteria (n=47,944), those with missing information on diabetes status and
explanatory variables were excluded from the analyses (n=5,589 or 11.7%), yielding a
final sample size of 42,355 adults. Most of the missing cases are from data on HbA1c
(n=4,743), resulting from the fact that some NHANES participants did not attend
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subsequent NHANES examination sessions after they were surveyed. Other missing
cases are from BMI, smoking behavior and education (n=846).

3.4.2 Variable Definitions
The main dependent variables are: (1) self-reported diagnosed diabetes; (2)
HbA1c measurement of at least 6.5% and (3) undiagnosed diabetes. Self-reported
diabetes is constructed based on the survey question “Other than during pregnancy, have
you ever been told by a doctor or health professional that you have diabetes or sugar
diabetes?” If answered “yes” to this question, then the respondents are assigned as
diabetic. Participants who answered “no” or “borderline” are considered as non-diabetic.
Participants with HbA1c ≥ 6.5% are categorized as diabetic based on the American
Diabetes Association criteria (ADA, 2010). In addition, among participants with HbA1c
<6.5%, those who were using insulin or taking diabetes pills are also considered as
diabetic, following previous literature (Stokes & Preston, 2017). Throughout the chapter,
I refer two diabetic groups, participants with HbA1c ≥ 6.5%, and HbA1c < 6.5% and
taking diabetes medication, as “HbA1c ≥ 6.5%.” Undiagnosed diabetes is defined as
having HbA1c ≥ 6.5% without self-reported diabetes.
Other covariates include age, nativity, race/ethnicity, sex, education, cigarette
smoking, BMI and survey years. Age is used as continuous. Race/ethnicity is constructed
based on self-reported ethnicity and categorized as non-Hispanic white (Whites
hereafter), non-Hispanic black (Blacks hereafter) and Hispanic. Nativity is categorized as
US-born or foreign-born: participants who reported being born in one of 50 US States or
Washington DC are coded as US-born, while those who reported being born in Mexico,
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another Spanish speaking country, or other foreign country are considered to be foreignborn. For the foreign-born, the survey further asked years spent in the U.S. and nine
categories of length of residence are provided in publicly available NHANES. In
preliminary analyses, I observed that there is little variation or inconsistency between the
categories less than 15 years in terms of the prevalence of self-reported diabetes and
HbA1c ≥6.5%, and mean HbA1c level (Table A2). Also, estimates for the short-duration
categories showed high level of uncertainty due to a small sample size. Therefore, I
collapsed the nine categories into two groups to obtain reliable estimates with statistical
power: (1) less than 15 years and (2) 15 years or longer US residence. Education was
coded into four categories: (1) less than high school; (2) high school diploma or general
educational diploma; (3) some college; and (4) four years of college or more. Smoking
behavior was coded as current, former, or never smoker based on two survey questions:
“Have you smoked at least 100 cigarettes in your entire life?” and “Do you now smoke
cigarettes?” I created a dichotomous variable for not having access to healthcare;
participants were coded as 1 if they reported they don’t have a place when they are sick
or need advice about health and 0 otherwise.
Baseline BMI (kg/m2) was measured as a continuous variable as well as
categorized into four classifications: under or normal weight (< 25.0 kg/m2), overweight
(25.0-29.9 kg/m2), obese class I (30.0-34.9 kg/m2) and obese class II/III (≥35.0 kg/m2). In
regression models, BMI was used as a continuous variable above BMI equal to 18.5
kg/m2 and values above 18.5 kg/m2 were coded as BMI value – 18.5 kg/m2. BMI values
below 18.5 kg/m2 were coded as 0. Also, a BMI squared term is used to reflect a possible
non-linear relationship between diabetes and BMI. In a preliminary analysis. Models with
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BMI and BMI squared showed better model fits than models with BMI as a categorical
variable.

3.4.3 Statistical Approach
After presenting descriptive information on the sample by nativity, agestandardized rates of three diabetes outcomes are presented for all covariates using the
2010 US-population age distribution by 5-year age intervals as the standard. To predict
nativity differentials in diabetes net of confounding factors, I estimate five multivariate
logistic regression models for the three outcomes. For undiagnosed diabetes, the analytic
sample is restricted to those with HbA1c levels greater than or equal to 6.5% among
those with undiagnosed diabetes and the model thus estimates the probability that
diabetes remains undetected. Model 1 includes nativity status, age, sex and survey year.
Model 2 further controls for education. Model 3 additionally adjusts for race/ethnicity.
Model 4 adds smoking behavior and having a place for healthcare. Model 5 further
controls for BMI and BMI squared. In Model 5, only BMI variables are additionally
introduced because I found a prominent role of BMI in explaining the nativity gap in
diabetes.
The effect of duration of US residence is tested in Model 6 and 7. In these models,
the foreign-born are divided into two groups by reported length of residence, less than 15
years and 15 years or longer duration of stay. These foreign-born groups are compared to
the native-born in both Models 6 and 7. Model 6 adjusts for the covariates used in Model
4, while Model 7 controls for the variables introduced in Model 5. After fitting these
models, predicted probability of the three diabetes outcomes are calculated based on
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coefficients from Model 7, which is a full model with all covariates, and results are
graphically presented in Figure 3-1.
Potential heterogeneity in associations by race/ethnicity is tested by including
interaction terms between race/ethnicity and nativity. The results from this analysis are
not shown as the interaction effects are found to be insignificant. To further investigate
the role of race/ethnicity in combination with nativity, an additional analysis is conducted
in which age-standardized prevalence of three diabetes outcomes and major covariates
are calculated by race/ethnicity and nativity (Table A3).

3.4.4 Sensitivity Analysis
Previous research of diabetes shows variation in their findings depending on the
definition of diabetes. To assess the effect of different definitions of diabetes on the
results of this chapter, I use three additional definitions of diabetes and estimate logistic
models with the new diabetes criteria. These definitions are (1) fasting plasma glucose ≥
126mg/dL only, (2) fasting plasma glucose ≥ 126mg/dL or HbA1c ≥ 6.5% (3) fasting
plasma glucose ≥ 126mg/dL, HbA1c ≥ 6.5% or self-reported diabetes. Undiagnosed
diabetes is also newly defined based on both FPG and HbA1c: having either HbA1c ≥
6.5% or fasting plasma glucose ≥ 126mg/dL, but did not report self-reported diabetes.
Because only NHANES respondents who attended morning fasting session had
information on plasma glucose level, the analyses are restricted to these respondents
(n=25,959).

3.5 Results
3.5.1 Descriptive Analysis
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Table 3-1 summarizes the descriptive information of the sample by nativity. Of
the 42,355 NHANES participants aged 30-80, 87.6% were US-born and 12.4% were
foreign-born individuals. Among the foreign-born, 36.7% and 64.7% lived in the US for
less than 15 years and 15 years or longer, respectively. The prevalence of self-reported
diabetes was higher for the foreign-born (10.1%) than the US-born (9.6%). When
diabetes was measured by HbA1c ≥ 6.5%, the same pattern was revealed: 12.2% of the
foreign-born and 11.0% of the US-born had diabetes. The prevalence of undiagnosed
diabetes among participants whose HbA1c levels were equal to or greater than 6.5% was
also higher for foreign-born individuals (28.6%) than the US-born (21.9%). The US-born
(52.0 years) were older than the foreign-born (47.9 years). Whites constituted the
majority of the US-born group (84.0%), while Hispanics (62.6%) accounted for the
largest share of the foreign-born, followed by Blacks (28.0%). The US-born had a in
general higher educational attainment than the foreign-born: nearly 40% of the foreignborn individuals had less than high school education, but only a quarter of the US-born
had the same educational attainment. US-born individuals showed a slightly higher mean
BMI (29.1 kg/m2) than the foreign-born (28.5 kg/m2). Looking at BMI classifications, the
US-born were less likely to be overweight (22.3% vs 41.1%) and obese classⅠ(20.8% vs
22.7%) than the foreign-born. However, the native-born were more likely to be obese
classⅡ/Ⅲ (16.2% vs 10.6%) and also be under or normal weight (28.6% vs 25.6%) than
the foreign-born. While most US-born adults reported that they have access to healthcare
services when they have a health problem (89.7%), a smaller proportion of the foreignborn reported such accessibility (76.1%). Among the foreign-born, 63.3% reported that
they had lived in the US for 15 years or longer.
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Table 3-2 presents age-standardized prevalence of diabetes outcomes by all
covariates. For undiagnosed diabetes, the prevalence among those with HbA1c ≥ 6.5%
and among the entire sample is separately presented. For all three outcomes, age-adjusted
prevalence among the foreign-born exceeded that of the US-born; self-reported diabetes
(11.4% vs 8.8%), HbA1c ≥ 6.5% (13.6% vs 10.1%) and undiagnosed diabetes (40.0% vs
26.7% among those with HbA1c ≥ 6.5% and who reported that they had not been
diagnosed with diabetes, and 3.7% vs 2.2% among the entire sample). Among foreignborn adults, those with longer duration of US residence had a higher prevalence of the
three diabetes outcomes than foreign-born adults with shorter duration of stay. Compared
with women, men had a slightly higher prevalence of self-reported diabetes (9.7% vs
8.5%), HbA1c ≥ 6.5% (11.5% vs 9.5%) and undiagnosed diabetes (29.7% vs 27.9%).
There were considerable racial/ethnic disparities in the prevalence of the diabetes
outcomes; Blacks and Hispanics were disadvantaged in self-reported diabetes (15.3% for
Blacks, 14.7% for Hispanics and 7.6% for Whites), HbA1c ≥ 6.5% (18.3% for Blacks,
17.2% for Hispanics and 8.6% for Whites) and undiagnosed diabetes (31.8% for Blacks,
32.1% for Hispanics and 26.0% for Whites) when compared with Whites. There was also
a clear educational gradient in the three outcomes with the less educated showing a
higher prevalence than the more educated. As expected, the age-adjusted prevalence of
self-reported diabetes, HbA1c ≥ 6.5% and undiagnosed diabetes increased sharply with
BMI. Participants with obese class II/III (BMI ≥ 35.0 kg/m2) had a particularly high
prevalence compared to any other BMI group. Among participants with obese class I (3034.9 kg/m2), for instance, the prevalence of self-reports, HbA1c ≥ 6.5% and undiagnosed
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diabetes was 11.8%, 14.3% and 3.5%, respectively, but the prevalence was very high at
19.6%, 24.2% and 6.2% in obese class II/III.

3.5.2 Results from Logistic Regression Models
Tables from 3-3 through 3-5 present logistic regression analyses for self-reported
diabetes (Table 3-3), HbA1c ≥ 6.5% (Table 3-4) and undiagnosed diabetes (Table 3-5).
All coefficients are expressed as a form of odds ratios (ORs). Analyses for undiagnosed
diabetes were performed among the participants with HbA1c ≥ 6.5% and individuals who
reported that they had not been diagnosed with diabetes. Model 1, which adjusts for
nativity, age and sex, shows that foreign-born individuals had 28% higher odds of
reporting self-reported diabetes (OR: 1.28, 95% CI: 1.13-1.45) relative to US-born
individuals. Similarly, foreign-born adults had 36% higher odds of having HbA1c ≥ 6.5%
(OR:1.36, 95% CI:1.22-1.51) compared to the US-born. The foreign-born were also more
likely to underreport their diabetes (OR: 1.40, 95% CI: 1.11-1.76) than the US-born.
Model 1 also shows that adjusted risk of diabetes among the sample has increased over
the period studied, while a decrease in the risk of undiagnosed diabetes was observed.
Model 2 additionally adjusts for educational attainment. In this model, nativity
differences in self-reported diabetes (OR: 1.08, 95% CI: 0.95-1.23) and HbA1c ≥ 6.5%
(OR: 1.15, 95% CI: 1.03-1.28) are reduced to some extent compared with Model 1.
However, odds ratio for undiagnosed diabetes increased from 1.40 (95% CI: 1.40-1.76 in
Model 1) to 1.46 (95% CI: 1.14-1.88 in Model 2). As expected, there was a strong
relationship of self-report of diabetes and HbA1c ≥ 6.5% with education. However, there
was no significant educational gradient with regard to undiagnosed diabetes.
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When race and ethnicity is introduced in Model 3, the foreign-born became
significantly less likely to have diabetes than the US-born and this change was observed
for both self-reported diabetes (OR:0.75, 95% CI:0.64-0.88) and HbA1c ≥ 6.5%
(OR:0.79, 95% CI:0.69-0.91). In addition, there was a strong association between
race/ethnicity and the excess prevalence of diabetes: when compared to Whites, Blacks
and Hispanics were more than twice as likely to have self-reported diabetes and HbA1c ≥
6.5% than Whites. For undiagnosed diabetes, the inclusion of race/ethnicity did not alter
the pattern observed in Model 1 and 2; foreign-born individuals were more likely to have
unknown diabetes than US-born Americans (OR:1.48, 95% CI:1.13-1.94). In addition,
the risk of undiagnosed diabetes did not significantly vary by race/ethnicity.
Model 4 further adds smoking behaviors and access to healthcare. Adjusting for
these variables slightly increases odds ratios of being-foreign born for self-reported
diabetes (OR:0.80, 95% CI:0.69-0.94) and HbA1c ≥ 6.5% (OR:0.83, 95% CI:0.73-0.95),
reducing gaps in the nativity difference in diabetes. Compared with never smokers,
former smokers had higher odds, while current smokers had lower odds of self-reported
diabetes and HbA1c ≥ 6.5%. Having access to healthcare was positively and strongly
associated with self-reported diabetes (OR: 3.51, 95% CI: 2.75-4.48) and HbA1c ≥ 6.5%
(OR: 2.35, 95% CI: 1.93-2.87). In contrast, there was a negative and significant
association between undiagnosed diabetes and having access to healthcare (OR: 0.33,
95% CI: 0.24-0.46).
The final model additionally controls for BMI and BMI squared. In this model,
the BMI variables retained their strong association with all three outcomes. In addition,
the inclusion of BMI diminished the foreign-born advantage with self-reported diabetes
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(OR: 0.97, 95% CI: 0.83-1.13) and HbA1c ≥ 6.5% (OR: 1.05, 95% CI: 0.91-1.21),
making the associations statistically insignificant. For undiagnosed diabetes, the odds
ratio of being foreign-born was almost intact (OR: 1.53, 95% CI: 1.16-1.21). As
expected, BMI was positively associated with having self-reported diabetes, HbA1c ≥
6.5%, and undiagnosed diabetes. Furthermore, controlling for the BMI variables
considerably reduced higher odds ratios for recent years compared with years 1988-1994,
indicating that increasing BMI in the US population has contributed to an increase in
prevalence of diabetes in recent years.
The association between the length of US residence and the diabetes outcomes is
tested in Model 6 and 7 (Table 3-6). In these models, the foreign-born sample was
divided by the duration of residence (< 15 years vs. 15+ years). In Model 6, the foreignborn with <15 years of residence had lower risks of self-reported diabetes (OR:0.59, 95%
CI: 0.48 – 0.74) and HbA1c ≥ 6.5% (OR:0.68, 95% CI: 0.56 – 0.83) when compared to
the US-born. However, foreign-born adults with 15 + years of residence did not have
such advantage in either self-reported diabetes (OR:0.88, 95% CI: 0.74 - 1.04) and
HbA1c ≥ 6.5% (OR:0.89, 95% CI: 0.77 - 1.03). In addition, both foreign-born groups by
duration of stay were significantly more likely to have undiagnosed diabetes than their
US-born counterparts. In Model 7 in which BMI and BMI squared are further introduced,
the lower risk of diabetes for foreign-born adults with < 15 years of residence observed in
Model 6 only remained significant for self-reported diabetes (OR:0.78, 95% CI: 0.620.98), but not for HbA1c ≥ 6.5% (OR:0.96, 95% CI: 0.77-1.18). In addition, the foreignborn with 15+ years of residence were not significantly different from the US-born in
either self-reported diabetes (OR:0.89, 95% CI: 0.77-1.03) or HbA1c ≥ 6.5% (OR:1.08,
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95% CI: 0.93-1.26). With regard to undiagnosed diabetes, both foreign-born groups had
significantly higher odds than their US-born counterparts. Furthermore, the magnitude of
the odds ratios of undiagnosed diabetes were found to be greater for those with <15 years
of residence than those with 15+ years of residence by 25-30%.
Figure 3-1 summarizes predicted probabilities of the three outcomes based on
coefficients of Model 7 in Table 3-6. When diabetes was measured based on selfreported, the foreign-born with <15 years of residence appeared to have a significantly
lower probability of having diabetes compared with the US-born as well as the foreignborn with 15+ years of residence. However, the foreign-born with 15 + years of residence
were not significantly different from the native-born. Despite this significant effect of the
duration of residence with regard to self-reported diabetes, there were no significant
difference between the US-born, the foreign-born with <15 years and 15+ years of
residence when diabetes was diagnosed based on the HbA1c criterion. For undiagnosed
diabetes, both foreign-born groups had a significantly higher probability than the USborn. Although two foreign-born groups did not significantly differ in terms of the
probability of undiagnosed diabetes, the probability was lower for the long-term foreignborn group than recent arrivals.

3.5.3 Results from the Sensitivity Analysis
Table 3-7 presents results from sensitivity analyses. These analyses test three
different definitions of diabetes using FPG: (1) FPG ≥ 126 mg/dL; (2) HbA1c ≥ 6.5% or
FPG ≥ 126 mg/dL; and (3) HbA1c ≥ 6.5%, FPG ≥ 126 mg/dL or self-reported diabetes.
Model 8 and Model 9 (Table 3-7) adjust for covariates used in Model 4 and Model 5
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(Table 3-3), respectively. These models with new definitions of diabetes show very
similar diabetes and nativity patterns observed in the previous models of self-reported
diabetes and HbA1c ≥ 6.5%. These observations suggest that the results from this chapter
are not affected by how diabetes is identified.

3.6 Discussion
Previous studies of diabetes have reported inconsistent or conflicting findings on
whether immigrants have a favorable diabetes status compared to their US-born
counterparts. One of the limitations in the literature is that most previous studies
identified diabetes based solely on self-reported diabetes. However, using self-reported
diabetes could provide inaccurate estimates of the actual risk of diabetes among the
foreign-born due to their limited healthcare use. Therefore, I reexamined this issue by
focusing on both self-reported diabetes, a HbA1c measurement and undiagnosed
diabetes. To the best of my knowledge, these are the first estimates of diabetes among
foreign-born vs. US-born individuals based on the three diabetes outcomes.
I found that the age-standardized prevalence of diabetes was higher among the
foreign-born than the US-born (Table 3-2). The higher risk of diabetes among the
foreign-born was also observed in logistic regression models in which age, sex, and
education were adjusted for (Model 1 in Table 3-3 and Table 3-4). However, controlling
for race/ethnicity reversed this pattern such that the foreign-born now had a significantly
lower risk of diabetes than the US-born (Model 3 in Table 3-3 and Table 3-4). With
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additional inclusion of BMI in the model, the significant difference in diabetes between
the foreign-born and the US-born disappeared (Model 5 in Table 3-3 and Table 3-4).
One of the main goals of this chapter is to assess a possible misclassification bias
from using self-reported diabetes. Results from logistic models for self-reported diabetes
(Table 3-3) and HbA1c ≥ 6.5% (Table 3-4) show that there was little difference in the
estimated odds ratios for these two measures. Furthermore, age-standardized prevalence
presented in Table 3-2 exhibits very similar values for self-reported diabetes and HbA1c
≥ 6.5%. These results suggest that estimates based on self-reported diabetes well reflect
the actual difference in the prevalence and relative risk of diabetes between the foreignborn and the US-born as a whole.
On the other hand, the results also show that the foreign-born had 53 percent
higher odds of having undiagnosed diabetes compared to the US-born (Model 5 in Table
3-5). This result implies the existence of a misclassification bias that is more serious for
the foreign-born relative to the US-born when diabetes is diagnosed based on self-reports.
Yet, as seen previously, the problem of underreporting diabetes does not stand out when
comparing results from logistic regression models for self-reported diabetes (Table 3-3)
and HbA1c ≥ 6.5% (Table 3-4). This is because the prevalence of undiagnosed diabetes
in the entire sample was very low at 2.2% among the US-born and 3.7% among the
foreign-born. That is, cases of undiagnosed diabetes were too small to make a notable
impact of undiagnosed diabetes when the entire sample is analyzed, although the relative
risk of unknown diabetes was much greater for the foreign-born than the US-born based
on HbA1c ≥ 6.5%.
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The impact of higher prevalence of undiagnosed diabetes among the foreign-born
becomes discernable with a consideration of duration of residence, which is graphically
described in Figure 3-1. Using self-reported diabetes, diabetes prevalence was positively
associated with longer residence in the US, supporting the acculturation hypotheses.
When diabetes is diagnosed based on HbA1c levels, however, there was no significant
differences among the US-born and the two foreign-born groups defined by duration of
residence. There was, however, significant difference between the US-born and the
foreign-born in undiagnosed diabetes with the difference being less pronounced for those
with longer duration in the United States. Altogether, findings from Figure 3-1 suggest
that the observed lower risk of self-reported diabetes for the foreign-born immigrants
with <15 years of US residence over the US-born and those with longer stay in the US
was a product of a higher probability of underreported diabetes among the immigrants
with shorter duration of residence. This finding suggests that foreign-born individuals
with longer duration of residence are more likely to have found out that they have
diabetes, perhaps because of their access to health care has improved over time
(McDonald and Kennedy 2004; Leclere, Jesen and Biddlecom, 1994). When diabetes is
measured by HbA1c criterion, there is no difference in diabetes prevalence among the
foreign-born by length of US stay. Thus, in contrast to other studies that used selfreported diabetes, there is no evidence here that duration of US stay results in an
increased risk of diabetes (Oza-Frank, Stephenson and Narayan, 2011; Oza-Frank et al.,
2013; Horlyck-Romanovsky et al.,2019).
Furthermore, I found that race/ethnicity plays an important role in understanding
nativity differentials in diabetes. Results from logistic regression models show that when
95

controlling for race/ethnicity the foreign-born are at a lower risk of self-reported diabetes
and HbA1c ≥ 6.5% compared with the native-born. This table shows that within each
racial/ethnic group foreign-born individuals had lower age-standardized prevalence of
diabetes than the US-born. Thus, when controlling for both nativity and race/ethnicity the
foreign-born have lower risk of diabetes than the US-born (Model 3, Table 3-3). Without
controls for race/ethnicity in Model 1, Table 3-3, the foreign-born have a higher risk of
diabetes than the native-born due to the fact that Whites make up 84% of the US born,
and they have a lower prevalence of diabetes (8.6%) than foreign-born Blacks (10.9%)
and Hispanics (11.5%), who make up 90.6% of the foreign-born.
This higher age-adjusted risk of diabetes among racial minorities, regardless of
their nativity status, is consistent with previous literature that demonstrates higher
morbidity rates among ethnic minority populations when compared to Whites (Herbeck
et al., 2013). Hispanics and Blacks in the US have been found to be disproportionately
affected by hypertension, asthma, arthritis, and chronic medical conditions than Whites
due to racial minorities’ lower SES, barriers to healthcare services, disadvantaged earlylife experiences (Aday 2001; Benjamin-Johonson et al, 2009; Cunninghmal et al, 2006;
Mertens et al., 2008; Braveman and Barclay, 2009).
I also found a profound impact of BMI on nativity differentials in diabetes, which
has also been reported in other studies (Ford et al., 2016; Kumar, Wong, Ottenbacher and
Snih, 2016). The distribution of BMI classifications by nativity (Table 3-1) and
corresponding age-standardized prevalence of diabetes (Table 3-2) suggests a possible
role of BMI. The weighted proportion of overweight (25.0-29.9 kg/m2) and obese
classⅠ(30.0-34.9 kg/m2) were lower among the US-born as compared to the foreign96

born, but the proportion of obese class Ⅱ/Ⅲ (≥ 35.0 kg/m2) was higher among the USborn (16.2%) than among the foreign-born (10.6%). In addition, high age-standardized
prevalence of diabetes was marked for obese class Ⅱ/Ⅲ (19.6% and 24.2% based on
self-report and HbA1c ≥ 6.5%, respectively). Given these distributions, it is likely that
the US-born adults with extremely high BMI contributed to the excess prevalence of
diabetes among the US-born. The important role of BMI in this chapter partly supports
the cultural buffering hypothesis: healthier lifestyles and diet of foreign-born individuals
are associated with their favorable health outcomes (Singh and Siahpush, 2002).
In addition, this chapter found weak support for the positive selection of migrants
in terms of diabetes. As shown in Table 3-2, foreign-born individuals as a group had a
higher age-standardized prevalence of all three diabetes outcomes than the native-born
individuals. When stratified by race/ethnicity, however, within each racial/ethnic group
the foreign-born had lower age-standardized prevalence of diabetes (Table A3 in
Appendix). This finding is consistent with prior evidence and the healthy migrant
hypotheses within race/ethnicity (Mehta & Elo, 2012; Cunningham et al., 2008). This
heath advantage is in part due to the lower prevalence of extreme BMI among the
foreign-born compared to the US-born.
In summary, this chapter has three main findings that provide important insights.
First, race/ethnicity and BMI play a critical role in understanding nativity disparities in
the risk of diabetes. Racial and ethnic minorities tended to have a higher prevalence of
diabetes than Whites and, at the same time, foreign-born individuals within the same
racial/ethnic group were found to have a lower prevalence than their US-born
counterparts. In addition, the overall sample mean of BMI masks high rates of people
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with extremely high BMI among US-born Americans. This high prevalence of obesity
among the US-born contributes to their higher prevalence of diabetes. Second, using selfreported diabetes and a measurement of HbA1c provides very similar estimates of the
prevalence of diabetes for both the US-born and the foreign-born. Third, this study also
confirms a misclassification bias when using self-reported diabetes among the foreignborn, which was greater for the foreign-born with shorter duration of stay in the United
States. However, the degree to which the bias affects the comparison of the risks of
diabetes between the US-born and the foreign-born in the sample was small because the
prevalence of undiagnosed diabetes in the entire sample was very small (2.4% among the
US-born and 3.5% among the foreign-born).
Several limitations of this chapter should be acknowledged. First, the crosssectional data within the US does not account for return migrants whose diabetes status
may differ from those remaining in the United States. Second, the length of US stay, i.e.,
the duration effect may vary by SES and other demographic characteristics of the
foreign-born (Li and Hummer, 2014; Cho et al., 2004). This possibility was not examined
because the sample size of the foreign-born is too small to categorize this group by
duration as well as other characteristics. Prior literature also suggests that duration of stay
in the United States may not accurately reflect the migrant’s exposure to the US
environment (Massey and Capoferro, 2004). In addition, each of the racial/ethnic groups
is made up of heterogeneous subpopulations in terms of their place of birth (HorlyckRomanovsky et al., 2019; Mehta & Elo, 2012; Elo et al., 2011; Oza-Frank & Narayan,
2010). Although foreign-born subpopulations from different origins are expected to have
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a different risk of diabetes, this chapter cannot examine this possibility due to data
limitations.
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TABLES
Table 3-1. Characteristics of the NHANES Sample by Nativity. Ages 30-80.
Weighted %
Diabetes
Self-reported diabetes
HbA1c ≥ 6.5%
Undiagnosed diabetesa
Male
Age at baseline, in years (SD)
Race/ethnicity
Non-Hispanic white
Non-Hispanic black
Hispanic
Educational attainment
Less than high school
High school graduate
Some college
4 years college +
Smoking behavior
Never smoker
Current smoker
Former smoker
BMI (kg/m2), mean (SD)
BMI classifications
Underweight or Normal (-24.9 kg/m2)
Overweight (25.0-29.9 kg/m2)
Obese class Ⅰ (30.0-34.9 kg/m2)
Obese class Ⅱ/Ⅲ (≥ 35.0 kg/m2)
Access to health care (yes)
Survey years
1984-1994
1999-2004
2005-2010
2011-2016
Duration of residence, in years
Less than 15 years
15 + years

US-born
(N= 33,839)
87.6

Foreign-born
(N= 8,516)
12.4

9.6
11.0
2.4 (21.9) b
47.5
52.0 (14.4)

10.1
12.2
3.5 (28.6) b
50.2
47.9 (11.5)

84.0
11.2
4.8

28.0
9.4
62.6

15.0
25.8
30.0
29.2

41.2
17.1
20.9
20.8

48.6
22.3
29.2
29.1(5.5)

61.7
15.7
22.6
28.5(5.9)

28.6
34.3
20.8
16.2
89.7

25.6
41.1
22.7
10.6
76.1

8.5
28.3
30.5
32.6

3.3
28.8
32.2
35.7

-

36.7
63.3

Percentages were calculated using NHANES survey weights.
Source: NHANES Ⅲ (1988-1994) and continuous NHANES 1999-2016.
a
Undiagnosed diabetes is defined as HbA1c ≥ 6.5% without self-reported diagnosed diabetes.
bWeighted prevalence of undiagnosed diabetes among participants with HbA1c ≥ 6.5%
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Table 3-2. Age-standardized Prevalence of Diabetes Outcomes by Covariates. Ages 30-80.
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Nativity
US-born
Foreign-born
Duration of residencec
Less than 15 years
15 + years
Sex
Male
Females
Race/ethnicity
Non-Hispanic white
Non-Hispanic black
Hispanic
Educational attainment
Less than high school
High school graduate
Some college
4 years college +
Smoking behavior
Never smoker
Current smoker
Former smoker
BMI classifications (kg/m2)
Normal weight (-24.9)
Overweight (25.0-29.9)
Obese class Ⅰ (30.0–34.9)
Obese class Ⅱ/Ⅲ (≥ 35.0)
Having healthcare
Yes
No
Survey years
1984-1994
1999-2004
2005-2010
2011-2016

Self-reported diabetes
%
95% CI

HbA1c ≥ 6.5%
%
95% CI

Undiagnosed diabetesa
%
95% CI

Undiagnosed diabetesb
%
95% CI

8.8
11.4

8.4-9.2
10.3-12.5

10.1
13.6

9.7-10.6
12.5-14.8

26.7
40.0

23.7-29.8
35.2-45.0

2.2
3.7

2.1-2.4
3.2-4.3

9.5
12.1

7.9-11.3
10.9-13.4

12.5
14.0

10.8-14.4
12.8-15.3

41.9
36.1

34.9-49.4
28.6-44.4

4.0
3.6

3.0-5.3
3.1-4.3

9.7
8.5

9.2-10.3
8.0-9.0

11.5
9.5

10.9-12.2
9.0-10.1

29.7
27.9

26.4-33.1
24.3-31.8

2.7
2.1

2.4-3.1
1.9-2.4

7.6
15.3
14.7

7.2-8.1
14.6-16.1
13.6-15.8

8.6
18.3
17.2

8.1-9.1
17.4-19.1
16.0-18.4

26.0
31.8
32.1

21.9-30.5
27.8-36.2
28.3-36.3

1.9
4.3
4.3

1.7-2.1
3.8-4.8
3.9-4.8

13.0
9.1
9.5
5.9

12.3-13.7
8.4-9.9
8.8-10.2
5.4-6.6

15.2
10.5
10.9
6.7

14.5-16
9.8-11.3
10.1-11.6
6.1-7.3

31.6
28.1
27.1
30.7

27.3-36.3
23.1-33.8
22.8-31.9
23.4-39.1

3.5
2.5
2.5
1.6

3.1-4.0
2.1-2.9
2.1-2.9
1.3-1.9

8.9
8.5
9.5

8.4-9.5
7.7-9.3
8.9-10.1

10.3
9.9
11.1

9.7-10.9
9.1-10.6
10.4-11.9

28.3
29.6
30.8

25.0-31.9
25.1-34.5
25.2-37.1

2.3
2.4
2.7

2.0-2.6
2-2.9.0
2.3-3.1

3.9
6.8
11.8
19.6

3.4-4.4
6.3-7.3
10.9-12.7
18.3-21.1

3.7
7.3
14.3
24.2

3.3-4.2
6.8-7.8
13.4-15.3
22.8-25.6

14.8
24.6
30.2
32.5

10.2-20.8
20.0-29.9
25.9-34.8
28.4-36.9

0.6
1.5
3.5
6.2

0.4-0.8
1.3-1.7
3.1-4.0
5.4-7.0

9.6
3.4

9.2-10.1
2.7-4.4

10.9
5.7

10.4-11.4
4.7-6.8

26.5
51.2

23.8-29.4
43.7-58.7

2.4
2.6

2.2-2.6
2.1-3.3

6.4
8.2
9.0
10.7

5.7-7.1
7.5-8.9
8.2-9.9
10.0-11.5

7.8
8.9
10.7
12.3

7-8.7.0
8.2-9.7
9.9-11.6
11.4-13.3

41.1
27.4
29.4
27.5

33.7-48.9
21.8-33.8
26.0-33.0
23.3-32.1

2.6
1.8
2.7
2.7

2.2-3.0
1.6-2.1
2.3-3.0
2.3-3.1

participants with HbA1c ≥ 6.5%. bAmong the entire sample. cAmong the foreign-born.
2010 US population for both men and women was used as the standard population.
aAmong

Table 3-3. Odds Ratios from Multivariate Logistic Regressions for Self-Reported Diabetes. Ages 30-80 (n=42,355).
Model 1
OR 95% CI
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Nativity
US-born (ref)
1.00 1.00-1.00
Foreign-born
1.28 1.13-1.45
Age, in years
1.05 1.05-1.05
Male
1.19 1.09-1.30
Educational attainment
< High school (ref)
High school graduate
Some college
4 years college +
Race/ethnicity
Non-Hispanic white (ref)
Non-Hispanic black
Hispanic
Smoking behavior
Never smoker (ref)
Current smoker
Former smoker
Having healthcare (Yes)
BMI (kg/m2)
BMI squared
Survey year
1988-1994 (ref)
1.00 1.00-1.00
1999-2004
1.31 1.12-1.53
2005-2010
1.47 1.26-1.72
2011-2016
1.78 1.55-2.05
ref: Reference group
NHANES survey design is accounted for.
Data source: NHANES 1988-1994 and 1999-2016.

OR

Model 2
95% CI

Model 3
OR 95% CI

OR

Model 4
95% CI

Model 5
OR 95% CI

1.00
1.08
1.05
1.22

1.00-1.00
0.95-1.23
1.04-1.05
1.12-1.33

1.00
0.75
1.05
1.24

1.00-1.00
0.64-0.88
1.05-1.05
1.14-1.35

1.00
0.80
1.04
1.29

1.00-1.00
0.69-0.94
1.04-1.05
1.18-1.42

1.00
0.97
1.05
1.40

1.00-1.00
0.83-1.13
1.05-1.06
1.28-1.53

1.00
0.68
0.69
0.40

1.00-1.00
0.61-0.76
0.61-0.77
0.34-0.46

1.00
0.77
0.79
0.48

1.00-1.00
0.69-0.86
0.70-0.88
0.42-0.56

1.00
0.74
0.74
0.44

1.00-1.00
0.66-0.83
0.66-0.83
0.38-0.51

1.00
0.74
0.73
0.52

1.00-1.00
0.66-0.83
0.65-0.82
0.45-0.60

1.00
2.10
2.08

1.00-1.00
1.91-2.30
1.81-2.39

1.00
2.10
2.16

1.00-1.00
1.91-2.31
1.89-2.48

1.00
1.82
1.97

1.00-1.00
1.65-2.01
1.72-2.26

1.00
0.90
1.09
3.51

1.00-1.00
0.80-1.01
1.00-1.18
2.75-4.48

1.00
1.14
1.06
3.18
1.18
0.99

1.00-1.00
1.00-1.29
0.97-1.15
2.49-4.05
1.16-1.20
0.99-0.99

1.00
1.28
1.47
1.84

1.00-1.00
1.10-1.50
1.26-1.72
1.60-2.12

1.00
1.10
1.18
1.42

1.00-1.00
0.94-1.28
1.01-1.39
1.24-1.64

1.00
1.39
1.60
2.03

1.00-1.00
1.20-1.61
1.38-1.86
1.77-2.33

1.00
1.34
1.53
1.88

1.00-1.00
1.15-1.56
1.31-1.78
1.65-2.16

Table 3-4. Odds Ratios from Multivariate Logistic Regressions for HbA1c ≥ 6.5%. Ages 30-80 (n=42,355).
Model 1
OR 95% CI
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Nativity
US-born (ref)
1.00 1.00-1.00
Foreign-born
1.36 1.22-1.51
Age, in years
1.05 1.05-1.05
Male
1.28 1.18-1.39
Educational attainment
< High school (ref)
High school graduate
Some college
4 years college +
Race/ethnicity
Non-Hispanic white (ref)
Non-Hispanic black
Hispanic
Smoking behavior
Never smoker (ref)
Current smoker
Former smoker
Having healthcare (Yes)
BMI (kg/m2)
BMI squared
Survey year
1988-1994 (ref)
1.00 1.00-1.00
1999-2004
1.17 1.00-1.36
2005-2010
1.45 1.25-1.69
2011-2016
1.66 1.44-1.92
ref: Reference group
NHANES survey design is accounted for.
Data source: NHANES 1988-1994 and 1999-2016.

OR

Model 2
95% CI

Model 3
OR 95% CI

OR

Model 4
95% CI

Model 5
OR 95% CI

1.00
1.15
1.05
1.31

1.00-1.00
1.03-1.28
1.04-1.05
1.21-1.42

1.00
0.79
1.05
1.34

1.00-1.00
0.69-0.91
1.05-1.05
1.23-1.45

1.00
0.83
1.05
1.38

1.00-1.00
0.73-0.95
1.04-1.05
1.27-1.50

1.00
1.05
1.06
1.56

1.00-1.00
0.91-1.21
1.05-1.06
1.43-1.70

1.00
0.67
0.67
0.38

1.00-1.00
0.61-0.75
0.60-0.75
0.33-0.44

1.00
0.77
0.78
0.47

1.00-1.00
0.69-0.85
0.70-0.87
0.42-0.54

1.00
0.74
0.74
0.44

1.00-1.00
0.67-0.83
0.67-0.82
0.38-0.50

1.00
0.73
0.72
0.52

1.00-1.00
0.65-0.82
0.65-0.81
0.45-0.59

1.00
2.31
2.13

1.00-1.00
2.11-2.52
1.86-2.44

1.00
2.32
2.19

1.00-1.00
2.12-2.54
1.92-2.51

1.00
2.01
1.99

1.00-1.00
1.84-2.19
1.73-2.28

1.00
0.88
1.10
2.35

1.00-1.00
0.79-0.99
1.01-1.21
1.93-2.87

1.00
1.13
1.08
2.09
1.22
0.99

1.00-1.00
1.00-1.27
0.98-1.19
1.71-2.54
1.20-1.24
0.99-0.99

1.00
1.15
1.47
1.73

1.00-1.00
0.99-1.34
1.25-1.71
1.49-2.00

1.00
0.95
1.14
1.27

1.00-1.00
0.82-1.11
0.98-1.32
1.10-1.46

1.00
1.24
1.59
1.90

1.00-1.00
1.07-1.44
1.37-1.85
1.64-2.21

1.00
1.19
1.51
1.76

1.00-1.00
1.02-1.39
1.29-1.76
1.52-2.03

Table 3-5. Odds Ratios from Multivariate Logistic Regressions for Undiagnosed Diabetes. Ages 30-80 (n=5,087).
Model 1
OR 95% CI
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Nativity
US-born (ref)
1.00 1.00-1.00
Foreign-born
1.40 1.11-1.76
Age, in years
0.99 0.98-1.00
Male
1.12 0.91-1.38
Educational attainment
< High school (ref)
High school graduate
Some college
4 years college +
Race/ethnicity
Non-Hispanic white (ref)
Non-Hispanic black
Hispanic
Smoking behavior
Never smoker (ref)
Current smoker
Former smoker
Having healthcare (Yes)
BMI (kg/m2)
BMI squared
Survey year
1988-1994 (ref)
1.00 1.00-1.00
1999-2004
0.54 0.42-0.69
2005-2010
0.65 0.50-0.85
2011-2016
0.44 0.34-0.58
Analytic sample is restricted to those with HbA1c ≥ 6.5%
ref: Reference group. NHANES survey design is accounted for

OR

Model 2
95% CI

Model 3
OR 95% CI

OR

Model 4
95% CI

Model 5
OR 95% CI

1.00
1.46
0.99
1.11

1.00-1.00
1.14-1.88
0.98-1.00
0.90-1.37

1.00
1.48
0.99
1.13

1.00-1.00
1.13-1.94
0.98-1.00
0.91-1.39

1.00
1.44
0.99
1.06

1.00-1.00
1.10-1.89
0.99-1.00
0.85-1.33

1.00
1.53
1.00
1.13

1.00-1.00
1.16-2.03
0.99-1.01
0.90-1.41

1.00
1.16
1.13
1.15

1.00-1.00
0.90-1.49
0.87-1.47
0.86-1.53

1.00
1.17
1.15
1.16

1.00-1.00
0.90-1.51
0.88-1.49
0.86-1.57

1.00
1.18
1.21
1.25

1.00-1.00
0.90-1.54
0.92-1.58
0.92-1.70

1.00
1.18
1.21
1.27

1.00-1.00
0.91-1.54
0.92-1.58
0.94-1.73

1.00
1.17
1.01

1.00-1.00
0.95-1.44
0.78-1.32

1.00
1.18
0.93

1.00-1.00
0.95-1.45
0.72-1.21

1.00
1.18
0.95

1.00-1.00
0.95-1.45
0.74-1.23

1.00
1.08
1.09
0.33

1.00-1.00
0.86-1.36
0.87-1.36
0.24-0.46

1.00
1.14
1.07
0.32
1.06
0.99

1.00-1.00
0.90-1.44
0.86-1.34
0.23-0.44
1.02-1.11
0.99-0.99

1.00
0.56
0.65
0.44

1.00-1.00
0.44-0.71
0.50-0.86
0.33-0.58

1.00
0.53
0.60
0.40

1.00-1.00
0.41-0.67
0.46-0.78
0.30-0.52

1.00
0.53
0.64
0.43

1.00-1.00
0.41-0.68
0.49-0.83
0.33-0.57

1.00
0.53
0.63
0.43

1.00-1.00
0.41-0.68
0.48-0.83
0.33-0.57

Table 3-6. The Effect of Duration of Residence on Diabetes Outcomes. Ages 30-80.
Self-reported diabetes
(n=42,355)
Model 6
Model 7
OR 95% CI
OR 95% CI
Nativity and duration
US-born (ref)
Foreign-born
< 15
15 +

HbA1c ≥ 6.5%
(n=42,355)
Model 6
Model 7
OR 95% CI
OR 95% CI

Undiagnosed diabetesa
(n=5,087)
Model 6
Model 7
OR 95% CI
OR 95% CI

1.00

1.00-1.00

1.00

1.00-1.00

1.00

1.00-1.00

1.00

1.00-1.00

1.00

1.00-1.00

1.00

1.00-1.00

0.59
0.88

0.48-0.74
0.74-1.04

0.78
1.03

0.62-0.98
0.87-1.22

0.68
0.89

0.56-0.83
0.77-1.03

0.96
1.08

0.77-1.18
0.93-1.26

1.82
1.33

1.21-2.75
1.01-1.77

2.01
1.40

1.33-3.05
1.05-1.87

105

Model 6 adjusts for age, sex, race/ethnicity, education, smoking behavior, access to healthcare and survey periods.
Model 7 additionally adjusts for continuous BMI and BMI squared.
aAnalytic sample was restricted to those with HbA1c ≥ 6.5%.
aUndiagnosed diabetes is defined as HbA1c ≥ 6.5% without self-reported diabetes.
ref: Reference group
NHANES survey design is accounted for.

Table 3-7. Sensitivity Analyses. Odds Ratios from Multivariate Logistic Regressions for Different Definitions of Diabetes. Ages 30-80
(n=25,959).
FPG ≥ 126 mg/dL
Model 8
OR 95% CI
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Nativity
US-born (ref)
Foreign-born
Age, in years
Male
Educational attainment
< High school (ref)
High school graduate
Some college
4 years college +
Race/ethnicity
Non-Hispanic white (ref)
Non-Hispanic black
Hispanic
Smoking behavior
Never smoker (ref)
Current smoker
Former smoker
Having healthcare (Yes)
BMI (kg/m2)
BMI squared
Survey year
1988-1994 (ref)
1999-2004
2005-2010
2011-2016

HbA1c ≥ 6.5% or FPG ≥ 126 mg/dL

Model 9
OR 95% CI

Model 8
OR 95% CI

Model 9
OR 95% CI

HbA1c ≥ 6.5%, FPG ≥ 126 mg/dL or
Self-reported Diabetes
Model 8
Model 9
OR 95% CI
OR 95% CI

1.00
0.77
1.05
1.48

1.00-1.00
0.65-0.92
1.04-1.05
1.32-1.66

1.00
0.95
1.06
1.62

1.00-1.00
0.79-1.14
1.05-1.06
1.44-1.83

1.00
0.79
1.05
1.47

1.00-1.00
0.67-0.93
1.04-1.05
1.32-1.65

1.00
0.98
1.06
1.63

1.00-1.00
0.82-1.16
1.05-1.06
1.45-1.84

1.00
0.79
1.05
1.40

1.00-1.00
0.67-0.94
1.04-1.05
1.25-1.55

1.00
0.97
1.06
1.53

1.00-1.00
0.82-1.16
1.05-1.06
1.37-1.71

1.00
0.82
0.74
0.49

1.00-1.00
0.71-0.94
0.64-0.85
0.41-0.59

1.00
0.82
0.74
0.58

1.00-1.00
0.72-0.95
0.64-0.85
0.48-0.69

1.00
0.82
0.73
0.48

1.00-1.00
0.71-0.94
0.64-0.84
0.40-0.57

1.00
0.83
0.73
0.56

1.00-1.00
0.72-0.95
0.63-0.84
0.47-0.67

1.00
0.83
0.75
0.49

1.00-1.00
0.72-0.94
0.65-0.86
0.41-0.58

1.00
0.83
0.75
0.57

1.00-1.00
0.73-0.95
0.65-0.86
0.48-0.68

1.00
1.98
2.07

1.00-1.00
1.77-2.23
1.77-2.42

1.00
1.73
1.90

1.00-1.00
1.55-1.94
1.61-2.24

1.00
2.21
2.09

1.00-1.00
1.98-2.46
1.79-2.42

1.00
1.94
1.91

1.00-1.00
1.74-2.16
1.63-2.24

1.00
2.17
2.14

1.00-1.00
1.95-2.42
1.85-2.48

1.00
1.90
1.97

1.00-1.00
1.70-2.12
1.68-2.31

1.00
0.91
1.09
1.96

1.00-1.00
0.78-1.05
0.96-1.24
1.59-2.41

1.00
1.16
1.07
1.74
1.18
0.99

1.00-1.00
1.00-1.35
0.93-1.22
1.41-2.14
1.16-1.21
0.99-0.99

1.00
0.92
1.10
1.90

1.00-1.00
0.80-1.06
0.97-1.25
1.52-2.37

1.00
1.19
1.08
1.69
1.19
0.99

1.00-1.00
1.03-1.38
0.95-1.24
1.36-2.09
1.16-1.22
0.99-0.99

1.00
0.93
1.10
1.99

1.00-1.00
0.81-1.08
0.97-1.24
1.62-2.45

1.00
1.20
1.08
1.78
1.18
0.99

1.00-1.00
1.03-1.40
0.95-1.22
1.45-2.18
1.16-1.21
0.99-0.99

1.00
1.32
1.87
2.14

1.00-1.00
1.11-1.57
1.59-2.20
1.81-2.53

1.00
1.14
1.53
1.66

1.00-1.00
0.95-1.36
1.31-1.80
1.40-1.96

1.00
1.18
1.68
1.92

1.00-1.00
0.99-1.40
1.44-1.97
1.64-2.26

1.00
1.01
1.36
1.47

1.00-1.00
1.00 1.00-1.00
0.84-1.20
1.13 0.96-1.33
1.18-1.58
1.54 1.33-1.79
1.25-1.73
1.78 1.52-2.07
All analyses were restricted to those who participated in MEC morning session. NHANES survey design is accounted for. ref: Reference group

1.00
0.96
1.25
1.36

1.00-1.00
0.81-1.15
1.08-1.44
1.16-1.59
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§

Figure 3-1. Predicted Probability of Self-Reported Diabetes, HbA1c ≥ 6.5% and Undiagnosed Diabetes.
USB: US-born individuals. FB: Foreign-born individuals
╪: Predicted probability is significantly different from that of U.S.-born individuals at the 0.05 level.
§: Predicted probability is significantly different from that of foreign-born individuals with < 15 years of duration at the 0.05 level.

╪

APPENDIX
Table A1. The Effect of Self-reported Diagnosed Diabetes and HbA1c on All-cause Mortality.
HR
95% CI
Diabetes status
HbA1c <6.5 % (Ref)
1.00
1.00,1.00
HbA1c ≥6.5 %
1.41
1.28,1.55
Undiagnosed diabetes (Ref)
Diagnosed diabetes
Race/ethnicity
Non-Hispanic White (Ref)
1.00
1.00,1.00
Non-Hispanic Black
1.13
1.02,1.26
Hispanic
0.87
0.78,0.98
Others
0.69
0.54,0.88
Male
1.55
1.42,1.69
Age at baseline
1.07
1.07,1.08
Educational attainment
Less than high school (Ref)
1.00
1.00,1.00
High school
0.86
0.78,0.95
< 4 years college
0.78
0.70,0.87
4 years college +
0.60
0.53,0.69
Smoking behavior
Never (Ref)
1.00
1.00,1.00
Current smoker
1.94
1.73,2.17
Former
1.26
1.15,1.39
Drinking status
Never (Ref)
1.00
1.00,1.00
Former drinker
0.93
0.82,1.04
Current drinker
0.82
0.72,0.92
BMI at baseline
0.97
0.97,0.98
Not having usual health care
1.03
0.88,1.20
Complications
Hypertension
1.20
1.10,1.30
Heart failure
2.18
1.93,2.46
Heart attack
1.14
1.01,1.29
Stroke
1.50
1.33,1.69
Cancer
1.32
1.20,1.45
Ref: Reference group
All models adjust for survey period.
Bold values are significant at the 95% confidence level.
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HR

95% CI

1.00
1.56

1.00,1.00
1.42,1.72

1.00
1.13
0.86
0.69
1.55
1.07

1.00,1.00
1.02,1.25
0.77,0.96
0.54,0.87
1.42,1.69
1.07,1.08

1.00
0.87
0.78
0.61

1.00,1.00
0.79,0.96
0.70,0.88
0.53,0.70

1.00
1.96
1.26

1.00,1.00
1.75,2.19
1.15,1.39

1.00
0.93
0.82
0.97
1.00

1.00,1.00
0.82,1.05
0.73,0.93
0.97,0.98
0.86,1.17

1.18
2.12
1.14
1.47
1.31

1.09,1.29
1.87,2.39
1.01,1.28
1.30,1.65
1.19,1.44

Table A2. Effect of Duration of Residence on Diabetes Outcomes.

Nativity and duration
US-born (ref)
Foreign-born
-5
5–9
10 – 14
15 +

Self-reports diabetes
Model 4
Model 5
OR
95% CI
OR
95% CI

HbA1c ≥ 6.5%
Model 4
Model 5
OR
95% CI
OR
95% CI

Undiagnosed diabetesa
Model 4
Model 5
OR
95% CI
OR
95% CI

1.00

1.00-1.00

1.00

1.00-1.00

1.00

1.00-1.00

1.00

1.00-1.00

1.00

1.00-1.00

1.00

1.00-1.00

0.59
0.59
0.60
0.88

0.38-0.92
0.40-0.86
0.43-0.83
0.74-1.04

0.78
0.79
0.78
1.03

0.50-1.21
0.54-1.16
0.56-1.11
0.88-1.22

0.61
0.64
0.75
0.89

0.44-0.86
0.45-0.89
0.56-1.00
0.77-1.03

0.85
0.92
1.05
1.09

0.61-1.18
0.65-1.29
0.77-1.43
0.94-1.26

0.87
0.95
1.37
1.08

0.51-1.48
0.56-1.59
0.90-2.09
0.86-1.36

1.21
1.36
1.93
1.34

0.71-2.03
0.80-2.31
1.27-2.94
1.06-1.70
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Model 4 adjusts for age- sex- race/ethnicity- education- smoking behavior- access to healthcare and survey periods.
Model 5 additionally adjusts for BMI and BMI squared.
aAnalytic sample was restricted to those with HbA1c ≥ 6.5%.
Undiagnosed diabetes is defined as HbA1c ≥ 6.5% without self-reported diagnosed diabetes.

Table A3. Distribution of Age-Standardized Prevalence of Self-reported Diabetes, HbA1c ≥ 6.5%, Undiagnosed Diabetes and BMI
Classifications by Race/Ethnicity and Nativity.
Whites
Blacks
Hispanics
USB
FB
USB
FB
USB
FB
N (%)a
19,967(95.5)
948(4.5)
9,203(89.4)
925(10.6)
4,669(35.2)
6,643(64.8)
Self-reported diabetes
8.6
6.7
15.1
10.9
14.5
11.5
HbA1c ≥ 6.5%
9.7
7.7
18.1
13.9
16.3
13.9
Undiagnosed diabetes
25.1
31.2
28.7
29.4
22.7
33.1
BMI classification
Under or normal weight
30.2
34.8
21.5
29.0
18.6
20.9
Overweight
35.0
37.7
29.4
41.1
34.3
42.5
Obese class Ⅰ
20.4
18.7
23.0
21.0
23.9
24.8
Obese class Ⅱ/Ⅲ
14.5
8.7
26.0
8.9
23.2
11.8
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aUnweighted

sample size and weighed percentage.
USB: US-born individuals. FB: Foreign-born individuals
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